Blog

When Can an Outcome Bond Fund Carbon Removal Equipment Before the Credits Exist?

The short answer: when three things are already in place before the bond is sold. A creditworthy buyer has signed a long-term offtake for the credits the equipment will produce. The credits themselves are durable and registry-verifiable, so “delivered” is a fact a third party can check. And the bond’s structure lets investors keep their principal while staking only their return on delivery. Citi’s $72 million Carbon Removal-Linked Note for Applied Carbon, closed this month, is the worked example — the first outcome bond Citi has tied to verified carbon removals.

The deal, in one pass

Citi issued a $72 million, 3.5-year, principal-protected note whose proceeds finance Applied Carbon’s mobile biochar deployment across Texas farmland. There are no conventional coupons. Investors receive payments linked to the generation, verification, and delivery of carbon removal credits the project produces — if the credits are not issued and delivered, the payments tied to them do not flow.

Applied Carbon’s equipment is the reason the financing has to arrive first. Its mobile pyrolysis units process crop residue directly in the field, converting agricultural waste into biochar in a single pass and applying it to the soil, where the carbon stays stored for hundreds of years. The machines have to be built and deployed before a single credit exists. That ordering — equipment, then credits, then revenue — is the whole problem the note is designed to solve.

Nuveen participated as a primary buyer, citing the note’s relative value, its impact reporting, and the credit backing of the project’s off-taker. Microsoft holds a long-term carbon credit purchase agreement with Applied Carbon, signed in 2022, covering a portion of the project’s credits. Sonia Battikh, Citi’s Global Head of Carbon Offsets Trading, framed the gap the structure fills: “The voluntary carbon market requires new financial structures to bridge the gap between investor capital and the long-term funding needs of carbon removal projects.”

The timing mismatch is the market’s core problem

Carbon removal projects spend money in the opposite order from the one lenders prefer. Conventional debt wants a revenue history; a removal project has a purchase contract and a field. Venture capital will fund the early stage, but it prices for equity upside and exits, not for fleets of field equipment that pay back over years of credit deliveries.

The World Bank named this exact mismatch when it issued its own credit-linked outcome bond for a Vietnam water-purifier project: projects need up-front financing for capital and operating costs, and the carbon credits arrive a year or more later, after verification. Its answer was the same shape as Citi’s — channel capital-market money in at the start, and link what investors earn to credits actually issued. The Citi note applies that development-finance pattern to a commercial removal developer, at commercial scale, with a corporate offtake standing behind the revenue instead of a donor.

How the structure re-slices the risk

Principal protection removes the risk institutional fixed income cannot hold. A pension-grade buyer cannot put client principal on whether a Texas biochar fleet hits its production plan. Protecting the principal takes that question off the table. What remains at risk is the return — and the return is allowed to depend on delivery, because that is the part the buyer is being paid to underwrite.

Delivery-linked payments keep the outcome incentive inside the security. In a conventional bond, the issuer owes the coupon whether or not anything is removed from the atmosphere. Here the payments exist only when verified credits are generated and delivered. The investor’s upside and the project’s environmental output are the same event, which is what “outcome bond” means when the label is earned.

The anchor offtake turns a delivered credit into a receivable. A verified credit with no buyer is inventory. A verified credit under a long-term purchase agreement with Microsoft is contracted revenue. The offtake is what lets a structurer model the cash flows, what lets Nuveen describe the note as credit-backed, and what separates this financing from a bet on future spot prices in the voluntary market.

What the offtake does — and what it does not do

The Microsoft agreement was signed in 2022, four years before this note. The bond did not create that demand; it borrowed against its credibility. That sequence matters for anyone hoping to copy the structure: the financing was possible because the revenue anchor predated it, not the other way around.

The limits deserve equal weight. The offtake covers a portion of the project’s credits, not all of them. The full credit volume, the delivery schedule, the price per credit, and the note’s exact return formula have not been disclosed publicly. An anchor offtake makes a project financeable; it does not, by itself, underwrite every tonne the equipment could produce, and no reader of this deal’s public record can verify the coverage ratio.

There is a second question the headline number cannot answer. In the World Bank’s $100 million plastic waste outcome bond — a deal Citi itself lead-managed — about $14 million of the headline was the up-front financing the projects actually received. Outcome-bond headlines describe the note, not the project capital. How much of this note’s $72 million reaches Applied Carbon as deployment capital, and on what schedule, is not in the public record either. It is the first question a diligence process should ask of any deal built this way.

When this shape works

The credits are durable and verifiable. The structure prices delivery, so delivery has to be measurable by an independent registry on a schedule the note’s term can contain. Biochar’s multi-century storage and established verification pathways fit; a credit class with contested permanence would not.

A creditworthy anchor buyer signed before the financing. The offtake is the revenue story the structurer sells to the bond buyer. Without it, there is nothing to link payments to except hope and spot prices.

Equipment is the bottleneck, not demand. This shape funds machines that produce contracted output. It does not fix a project whose problem is finding buyers.

The developer can survive the verification lag. Payments follow issued credits, and issuance trails production. A developer without the balance sheet — or the structurer’s up-front allocation — to bridge that gap will stall between making biochar and getting paid for it.

Applied Carbon’s founder and CEO, Jason Aramburu, described the ambition plainly: projects like his “can be structured and financed like any other asset.” This note is evidence for a narrower and more useful claim. A removal project can be financed like an asset when a named buyer has already agreed to purchase its output, the output can be verified by someone other than the seller, and the financing is honest about which risks sit with the principal and which sit with the return. Where any one of those three is missing, the outcome bond is not a shortcut. It is a label.

Deal coverage: ESG News, ESG Post, Carbon Herald, and CarbonCredits.com, October 2026 — terms consistent across all four. Outcome-bond precedent: World Bank outcome bond program materials, including its Emission Reduction-Linked Bond and Plastic Waste Reduction-Linked Bond documentation. Undisclosed items are noted in the text where they occur.

October 22, 2026
When Can Insurance Replace Part of a Carbon Buffer Pool Without Weakening Reversal Protection?
On October 20, carbon removal registry Isometric introduced an insurance framework, developed with broker Marsh, that lets developers of Isometric-certified reforestation projects replace part of their buffer pool contributions with insurance. Five providers — Artio, CarbonPool, CFC, Kita and Oka — are approved to offer the coverage, and other insurers can apply to join. The promise is straightforward: fewer certificates locked in reserve, more revenue in a project’s early years.

The question that decides whether this is progress or dilution is narrower: under what conditions can an insurance policy stand in for part of a buffer pool without weakening the reversal protection the pool exists to provide?

What the buffer pool is doing in the first place

A buffer pool is the carbon market’s self-insurance. A share of every project’s issued certificates is withheld into a shared reserve instead of being sold. If a project later loses stored carbon — a wildfire, a disease outbreak, a failed plantation — certificates from the pool are cancelled against the loss, so a credit a buyer already retired still represents a tonne of carbon removed. It is the same integrity machinery we walked through in how carbon credits are accounted for under the GHG Protocol.

The cost of that protection is real, and it is timed badly. Withheld certificates cannot be sold, and the withholding bites hardest in a project’s early years, when planting and operating costs are at their peak and revenue is thinnest. Every certificate in the pool is integrity you can point to — and cash the project does not have.

What the framework actually changes

Two features of the design matter more than the headline. First, the substitution is partial: insurance replaces part of a project’s buffer contribution, not the buffer itself. Marsh’s Hema Mistry, CEO of FINPRO UK at Marsh Risk, describes the framework as establishing requirements for using insurance alongside existing buffer mechanisms. Second, it is gated: the policy must meet Isometric’s requirements and come from a provider the registry has approved. The registry, not the developer, decides what counts as an adequate substitute.

Isometric’s chief commercial officer, Lukas May, states the design intent plainly: the framework gives developers “more flexibility when the economics matter most, without compromising on the safeguards that ensure every certificate buyers retire represents a tonne of carbon removed from the atmosphere.” Bruno Figueiredo, VP of Finance at reforestation developer Mombak, calls it “an important step toward a more mature carbon market,” arguing insurance can give buyers greater certainty while developers manage reversal risk more efficiently.

When substitution holds up — and when it weakens protection

Whether an insured buffer is as strong as a stocked one depends on terms that are not yet public. Isometric has not disclosed pricing, coverage limits, eligibility thresholds or an implementation date — so the honest answer today is conditional. The conditions that decide it:
- The insured perils must match the pool’s perils. The pool absorbs reversals from fire, disease and project failure alike. A policy that covers fire but excludes disease or insolvency substitutes for only part of the risk while releasing the whole contribution.
- The payout must restore certificates, not just compensate the developer. Buffer protection runs to the buyer and the registry: reversed tonnes get cancelled and replaced. A cash payment to a developer who may no longer be operating does not, by itself, retire a replacement tonne.
- The term must face the horizon. Reversal obligations run for decades; insurance is typically written in years. Substitution holds only if renewal, replacement or registry step-in rights are enforced for as long as the certificates are outstanding.
- The residual buffer must cover what the policy excludes. Partial substitution is the framework’s own safeguard — the remaining pool has to be sized against the uninsured remainder of the risk, not just reduced by a fixed percentage.
- The gate must be real. Approved-provider status is the mechanism that keeps substitution from becoming a race to the cheapest paper. Who approves, on what capital and claims standards, and what happens when a provider exits, decides whether the gate holds.
Why this matters beyond reforestation

Isometric says it is exploring whether the framework can extend to other removal pathways beyond reforestation. If it does, the pattern generalizes: reversal risk starts being priced by underwriters instead of being absorbed silently by a pooled reserve. That is what Figueiredo’s “more mature market” line actually points at — a market where integrity has a priced, inspectable instrument behind it rather than only a withheld percentage.

It also changes the buyer’s diligence question. “How large is the buffer?” was always a proxy. The better question, once insurance enters the structure, is “what stands behind the buffer — certificates in a pool, a policy from an approved carrier, on what perils, for how long, and paying whom?” A framework that forces that question into the open strengthens the market even before a single policy is bound. One that leaves the terms undisclosed will be judged, fairly, on the first reversal that tests it.

We cover the broker’s side of this framework — what to check before placing the coverage — at Risk Coverage Hub.
October 21, 2026
My D.C. Building Missed the BEPS Standard. What Pathways Are Still Open to Me?
The District’s own Building Energy Performance layer, updated in October 2026, marks 801 properties as not meeting the Building Energy Performance Standard, against 1,038 marked as meeting it. The mark is not a prediction or a peer comparison. It is the Department of Energy and Environment (DOEE) judging your building against the standard for its property type, on your building’s own reported record — and the first compliance cycle closes on December 31, 2026.

That sounds final, and for the standard itself it is. But missing the standard was never the end of the program: a building below the line enters a compliance cycle and works one of several pathways instead. If your building is one of the 801, the live question is not whether you missed. It is which pathway your building is on, and what that pathway still lets you do with the weeks left in this cycle.

What “missed” actually means for your building

The standard is a median, set by property type. For the first BEPS period, DOEE set each property type’s standard at no lower than the local District median from 2019 benchmarking data — an ENERGY STAR score for building types that receive one (71 for offices, 66 for multifamily housing, 54 for hotels, 50 for hospitals, 36 for K-12 schools), or a source energy use intensity figure for types that do not. By construction, a median standard puts roughly half of each property type below the line at the start.

Your status comes from your own 2019 record. A building entered the first compliance cycle if its reported 2019 metric fell short of its property type’s standard. Group improvement does not lift an individual building out: across buildings that filed in-compliance reports in both 2019 and 2024, the median building cut its weather-normalized energy use intensity by 11.2%, per an analysis of the District’s benchmarking disclosures — yet the 801 count is made of individual buildings whose own records still sit below their standard.

Cycle 1 covers the largest buildings first. The first cycle applies to privately owned buildings of 50,000 square feet and above, and to District-owned buildings of 10,000 square feet and above. Owners can check any building’s current standing in the Building Energy Performance disclosure on Open Data DC — the same public layer behind the 801 figure — which shows whether the building meets the standard and which compliance pathway, if any, is approved for it.

The four pathways, one by one

A building that does not meet the standard complies by completing an approved pathway. DOEE’s rules offer four for this cycle, and they demand very different things from an owner.
- Performance pathway — cut your own energy use by a fifth. The building demonstrates a 20% reduction in site energy use intensity against its baseline, which for this cycle is the average of its 2018 and 2019 site EUI. Compliance is judged on the building’s site EUI in 2026, the last year of the cycle. This is the pathway for owners whose buildings have already made deep cuts since 2019, whatever their property type’s standard says.
- Standard target pathway — reach the standard itself by the final year. The building meets the reported standard for its property type in 2026. This route is only available where the District’s standard is at least as energy efficient as the national median, and it suits buildings that started close to the line: one strong final year can close a small gap.
- Prescriptive pathway — do the agreed work, in four documented phases. Available only in Cycle 1, this pathway replaces a numeric target with a plan: an energy audit (Phase 1), a final list of efficiency measures and an operations and maintenance program under a signed final action plan agreement (Phase 2), an implementation report with permits and inspection records (Phase 3), and an evaluation, monitoring, and verification report (Phase 4). The agreed measures must be designed to save energy comparable to the performance pathway.
- Alternative compliance pathway — propose your own plan, with DOEE’s approval. An owner can put forward a custom plan — a deep energy retrofit is the classic case — as long as it is designed to achieve savings comparable to the performance pathway and DOEE approves it. This is the route built for buildings whose realistic fix is a major project rather than a series of small measures.
Owners were required to select a pathway by April 3, 2023, on the COVID-adjusted timeline, so most buildings in the cycle are already enrolled on one of these four. If you do not know your building’s pathway, the disclosure record is the first place to look — and if the record shows no approved pathway this late in the cycle, that gap is itself the most urgent item on your list.

What is still open this late in the cycle

The measured year is 2026, and it is not over. Both numeric pathways are judged on the building’s 2026 performance — its site EUI for the performance pathway, its standing against the property-type standard for the standard target pathway. Work and operational changes that land in 2026 still count toward the number DOEE will evaluate in 2027. A building that is close on either measure is not out of time; it is in its final measured quarter.

Enrolled pathways pay off in completed milestones, not intentions. A prescriptive-pathway building is judged on its phase reports: audit, signed action plan, implementation report, and the final evaluation, monitoring, and verification report. An alternative-compliance building is judged against the plan DOEE approved. Owners who chose those routes should be closing documentation now, because an implemented measure with no report behind it does not demonstrate compliance. The same discipline drives the Retrofit Priority Stack for Existing Buildings: sequence the measures, then prove them.

Your final data is a compliance asset in its own right. DOEE evaluates the cycle on reported benchmarking data, and the penalty rules reserve the harshest treatment for owners who withhold information, submit inaccurate information, or fail to file a complete and accurate final benchmarking report. Accurate, verified 2026 data is what converts real progress into a smaller payment — the same reason benchmarking is the prerequisite layer under every building performance law, not paperwork that follows it.

The delay and relief routes

A delay of up to three years exists for buildings with a genuine reason. DOEE can delay a building’s compliance deadline where the owner demonstrates grounds such as a change of ownership, a major renovation, or a pending demolition. Affordable housing buildings can qualify for delays longer than three years. Under the BEPS Amendment Act of 2024, the one-year COVID extension of Cycle 1 no longer consumes part of that three-year allowance, so an approved delay can still run the full three years.

Financial distress is now an explicit route, not an informal ask. In August 2026, DOEE issued version 1.2 of the BEPS Compliance and Enforcement Guidebook, which clarifies exemption flexibility for owners facing financial distress, adds detail on remedying non-compliance, and explains how the rules treat non-income-producing buildings. An owner whose barrier is money rather than engineering should read the relief sections of the current guidebook before assuming the only choices are the full retrofit or the full payment.

A delay is a pause, not an eraser. An approved delay does not extend the deadlines of the next compliance cycle, and it does not remove the requirement waiting at the end of it. Treat it as financed time to execute the plan: the building re-enters the next cycle with the same standard problem and less room to argue surprise.

What it costs if you fall short anyway

The payment is scaled to your floor area, then scaled again to your progress. A building that does not demonstrate compliance by the end of the cycle owes what the rules call an alternative compliance payment. The maximum is $10 per square foot of gross floor area, capped at $7,500,000 per building. The actual payment is reduced in proportion to the performance the building did demonstrate against its pathway target — a building that got most of the way there pays for the distance left, not the whole journey.

The maximum, with no progress credit, is reserved for bad records. DOEE can assess the maximum payment regardless of demonstrated performance where an owner knowingly withholds information, submits inaccurate information, fails to submit a complete and accurate benchmarking report at the end of the cycle, or implements a measure that threatens occupant health, safety, or indoor environmental quality. Separate fines can also attach to reporting violations and missed deadlines during the cycle itself.

The bill arrives after the evaluation year. DOEE’s evaluation and enforcement for Cycle 1 begins in 2027, on the strength of the 2026 record. The payment is therefore knowable in advance, and it shrinks with documented progress — which makes it weighable, honestly, against the remaining cost of the work, the same arithmetic owners run when they treat a performance law as a business continuity and insurance question, not just an energy question.

The owner’s checklist for the rest of 2026

None of the pathways reward waiting, and the cycle’s remaining weeks are worth more to a building below the line than to one above it. Before December 31, 2026, an owner of a marked building should be able to answer five questions without guessing.
- Status: What does the Building Energy Performance disclosure show for my building today — meets, does not meet, and which approved pathway?
- Measure: On 2026 data so far, how far is my building from its performance-pathway cut and from its property-type standard?
- Milestones: If I am on the prescriptive or alternative compliance pathway, which phase reports are still unfiled?
- Relief: Do I have grounds for a delay — ownership change, major renovation, pending demolition, financial distress — and has the application gone in?
- Record: Is my final benchmarking data complete, accurate, and verified, so the progress I have made is the progress DOEE sees?
The 801 figure will shrink or hold on the strength of those five answers, building by building. The standard was always judged on your own record. The pathways are how the record gets rewritten.
October 20, 2026
What Does It Prove When the Carbon Number Arrives With the Delivery?

For most contractors, an embodied-carbon figure is built backwards. The materials arrive, the job proceeds, and weeks later someone assembles what was bought from delivery tickets and invoices, then hunts down an emissions factor for each line. Travis Perkins, the UK builders’ merchant group, is now attacking that sequence from the other end: its Connect platform attaches a carbon dioxide equivalent (CO2e) value to products on orders and delivery records, so the number arrives with the goods instead of being reconstructed after them.

The group says it has mapped product weights in tonnes and kilograms and applied a CO2e figure to more than 120,000 products, and it is expanding Connect across five of its distribution businesses — Travis Perkins, CCF, Keyline, BSS, and Travis Perkins Managed Services. Connect began at CCF, the group’s interiors business; the October announcement is the group-wide rollout and the newly reported mapping scale. This is a British merchant’s platform in a British rollout. Nothing about it is on sale in the United States — what travels is the pattern.

The human stake is in the number the group’s announcement keeps returning to. Phil Monkman, who led the CCF team that built Connect, describes the old way in the announcement: “Up to now, the only way to get really accurate carbon data has been for the subcontractor to download delivery tickets and invoices and manually input the information, line-by-line. For some this could mean inputting up to 3,000 data points a month, just for carbon reporting.” That figure is one supplier’s description of some subcontractors’ burden, not a measured saving — but anyone who has assembled a Scope 3 inventory from a subcontractor’s spreadsheet knows the workload it names.

Three thousand hand-keyed data points a month is not just slow. It is where carbon reporting quietly goes wrong: a transposed digit, a quantity entered in the wrong unit, a factor grabbed from the wrong table at 11 p.m., a gap filled with a plausible number because the filing was due. Attaching the factor at the merchant’s end does not exhort that weakest link to try harder; it removes the link. The transcription step disappears, and with it an error surface that came free with every line.

What it proves — and what it doesn’t

What the delivery-attached number genuinely proves is provenance. Each line carries the product, quantity, weight, and the factor applied, on a transaction record that already exists for commercial reasons. An auditor, a client’s sustainability team, or your own assurance provider can walk that chain line by line. A month-end estimate cannot offer the same walk; it can only be believed or doubted as a whole. For data heading toward assurance — which California’s SB 253 builds in as its Scope 3 requirements phase in from 2027 — provenance is most of the game.

What it does not prove is precision, and the distinction lives in the factor library. Travis Perkins says its factors come from manufacturers’ environmental product declarations — EPDs — where those exist, and from recognized industry datasets everywhere else. Those are two different grades of evidence. An EPD is a manufacturer-specific, independently verified declaration with defined life-cycle boundaries. A generic dataset value is an average for a product class: a reasonable estimate wearing a uniform. A delivery total that blends the two is only as strong as its mix, and the group does not publish what share of its 120,000 mapped products is declaration-backed.

The boundary matters

The boundary matters as much as the grade. A product-level figure describes the material — typically manufacture up to the merchant’s gate. It is not a life-cycle assessment of the building: transport to site, installation, replacements across decades of use, and end of life sit outside the frame unless someone adds them. Nor does one merchant’s platform cover a project. Materials bought from any other supplier arrive the old way, numberless, and a contractor reporting on the whole job still has to reconcile covered and uncovered piles without double-counting.

The group’s own customer accounts hint at why the trade is still worth making. In one account the company tells, a contractor’s earlier estimate came in roughly 60 percent below the figure the delivery data later produced — a supplier-told story, not a validated error rate. But the direction is familiar to anyone who has compared a first-pass estimate with a counted inventory: hand-built numbers drift, usually downward, because the person building them is tired, rushed, and missing half the tickets.

The questions to ask your own merchants

So the useful response for a US or Canadian contractor is not envy of a UK platform; it is a set of questions for your own merchants and distributors, because the pattern is now demonstrably buildable. Which of my regular lines can you attach carbon data to, and which of those factors are declaration-backed rather than generic? What share of my tonnage does each grade cover? How often is your factor library updated, and are past deliveries restated when a factor changes? And can I have the data line by line, in a file my reporting system can ingest — or only as a printed total I have to re-key — rebuilding the weakest link this pattern exists to remove?

The delivery record was always the most trustworthy document on a construction job. It is signed, priced, and argued over; nobody invents one for fun. What is changing — in this UK rollout first, and in the questions it teaches buyers to ask everywhere else — is that the record now carries the carbon alongside quantity and price. When it does, the argument about your Scope 3 number moves from whether you counted at all to what grade of evidence you counted with. That is a better argument, and it is the one assurance providers, clients, and California’s filing calendar are about to have with you.

October 19, 2026

California’s First SB 253 Filing: The November 10 Compliance Checklist

On October 12, 2026, the California Office of Administrative Law approved the California Air Resources Board’s Initial Regulation for SB 253, and the regulation took effect the same day. That approval locked the date every covered company now has to work to: the first Scope 1 and Scope 2 emissions reports under the Climate Corporate Data Accountability Act are due to CARB on or before November 10, 2026.

This is not a proposed rule and it is not a distant phase-in. It is a live filing, roughly three weeks out, for U.S. companies with more than $1 billion in annual revenue that do business in California. What follows is the practitioner version: exactly who is covered, which fiscal year goes into the first report, the ways CARB will accept the filing, what assurance does and does not require this year, and the preparation steps that still fit in the time left.

The filing in one table

Item	What the approved rule requires
Who files	U.S.-organized business entities with revenue over $1 billion that do business in California
First deadline	November 10, 2026
Scopes in the 2026 report	Scope 1 and Scope 2 only — Scope 3 is not required this cycle
Data year	Prior fiscal year, selected under the February 1 rule below
How to file	CARB’s voluntary 2026 Report Intake Platform, or email to [email protected]
Assurance	Limited assurance is the statutory standard from 2026, but CARB accepts 2026 filings with or without it
Fee	Annual, formula-based; CARB issues fee determination notices by December 10, payment due within 60 days
Penalty ceiling	Up to $500,000 per reporting year for nonfiling, late filing, or other failure to comply
Records	Keep the California tax records behind your applicability determination for five years

Who must file — and who is out

The regulation defines a “reporting entity” as a partnership, corporation, limited liability company, or other business entity formed under the laws of California, another U.S. state, the District of Columbia, or an act of Congress, with total annual revenues in excess of $1 billion, that does business in California.

Three details of that definition decide most borderline cases. First, revenue means gross receipts, as defined in California Revenue and Taxation Code section 25120(f)(2). Second, the revenue test uses the lesser of the entity’s two previous fiscal years — one exceptional year does not pull an entity in, and one soft year does not let it out. Third, the test is applied entity by entity, at the individual business entity level; revenue from intercompany transactions inside the same combined reporting group does not count toward the threshold.

“Doing business in California” is also a defined term, not a vibe. It means doing business under Revenue and Taxation Code section 23101(a) and meeting either the section 23101(b)(1) or the section 23101(b)(2) test. Wholesale electricity sales in interstate commerce do not count toward the (b)(2) sales test. CARB’s guidance is explicit that entities are responsible for determining their own applicability — there is no approval step where CARB confirms your status for you.

Five categories are outside the article entirely:

Tax-exempt nonprofit or charitable organizations
Business entities regulated by the California Department of Insurance, or in the business of insurance in any other state
Federal, state, and local government entities, and companies majority-owned (over 50 percent) by government entities
Entities whose only California activity is wholesale electricity transactions in interstate commerce
Entities whose only California business is employee compensation or payroll expenses, including teleworking employees

One structural relief valve matters for groups: reports may be consolidated at the parent-company level. A covered subsidiary does not have to file separately if its parent files a consolidated report that includes it.

Which fiscal year goes in the first filing

The first report covers a prior fiscal year, and section 96076(c) of the regulation picks which one by a February 1 line:

Fiscal year ends on or before February 1 in a calendar year → report the fiscal year ending in the current calendar year.
Fiscal year ends after February 1 → report the fiscal year ending in the previous calendar year. The entity may instead choose its most recent preceding fiscal year, if that data is available.

Worked through the common cases: a calendar-year filer reports its 2025 fiscal year. A company whose fiscal year ends June 30 reports the year that ended June 30, 2025 — but may elect the year ended June 30, 2026 if the data is ready. A company whose fiscal year ends January 31 reports the year ended January 31, 2026, because that year ends in the current calendar year under the first branch of the rule.

Scope for this cycle is deliberately narrow. Scope 1 is direct greenhouse gas emissions from sources the entity owns or directly controls, regardless of location, including fuel combustion. Scope 2 is indirect emissions from purchased or acquired electricity, steam, heating, or cooling, regardless of location. Scope 3 — the value-chain inventory — is not part of the 2026 report; under the statute it begins in 2027. Emissions are measured and reported in conformance with the Greenhouse Gas Protocol’s standards and guidance.

The no-data door, stated precisely

For the November 10, 2026 report only, the regulation carries forward CARB’s December 5, 2024 Enforcement Notice. A covered entity has two options:

(A) Submit Scope 1 and Scope 2 emissions from its prior fiscal year that can be determined from information it already possessed or was already collecting on or before December 5, 2024; or
(B) Submit a statement of non-reporting on company letterhead stating that it is not submitting a report because it did not possess Scope 1 or Scope 2 information and was not collecting it on or before December 5, 2024.

CARB asks that the statement be submitted through the intake platform or by email before November 10, 2026. Read this door for exactly what it is: a one-cycle enforcement-discretion posture for the first report, not an exemption from SB 253. An entity that uses it is still a reporting entity, still owes the fee, and still needs a real inventory for the next cycle. Our earlier briefing walks through the three doors into the filing in more depth.

How to file in 2026

CARB built a 2026 Report Intake Platform, and its status surprises people: use of the platform is voluntary, not mandatory. Ahead of the deadline it can carry your contact information, your Scope 1 and 2 report through its submission fields, and the billing information CARB needs for fee invoicing. The alternative route is plain email — send the emissions report and contact information to [email protected].

The first-year formats are equally pragmatic. CARB’s September 1, 2026 reporting guidance accepts an existing annual report that includes Scope 1 and 2 emissions, existing Scope 1 and 2 data already reported to other programs or voluntary initiatives, or CARB’s Draft Scope 1 and 2 GHG Reporting Template — which is itself voluntary for 2026. For Scope 2, no single factor dataset is mandated this year: EPA eGRID 2023, the Cornerstone Sustainability Data Initiative’s eGRID 2024, or other credible sources may be used, provided the filing identifies the factors and sources behind the numbers.

CARB also encourages filers to include the context around the numbers — methodologies, data sources, global warming potential values, emission factors, organizational boundaries, disaggregation by category and gas, and assumptions. That context is encouraged rather than mandated in the first-year guidance, but it is the cheapest defensibility a filer can buy: it is the record that shows how each number was produced.

Assurance: the requirement versus the first-year enforcement

The statute sets a real assurance ladder. Health and Safety Code section 38532 requires independent third-party assurance of the disclosure: limited assurance for Scope 1 and 2 beginning in 2026, rising to reasonable assurance beginning in 2030.

The first-year enforcement posture is different from the requirement, and conflating the two is the most common error in coverage of this filing. CARB’s FAQ and its September 2026 guidance state that CARB will accept 2026 submissions whether or not assurance has been obtained. The obligation did not move; the enforcement did. Assurance requirements for 2027 and beyond are part of CARB’s second rulemaking and are not settled by the Initial Regulation — so the correct 2026 posture is to file on time, and to build the inventory so that it can survive limited assurance when the second rulemaking lands.

Fees, penalties, and the five-year file

The fee is an annual implementation fee assessed per reporting entity, calculated by formula: CARB’s program costs are recovered across the number of covered entities, with contingency and debt components in the calculation. The approved regulation sets the mechanics, not a fixed dollar figure — anyone quoting you an exact per-company fee for 2026 is quoting an estimate, not the rule. CARB issues fee determination notices by December 10, and payment is due within 60 calendar days of the notice. A parent may pay on a consolidated basis, but the fee is still assessed per covered entity.

The penalty exposure sits in the statute. CARB’s penalty regulations may reach nonfiling, late filing, or other failure to meet the law’s requirements, and penalties imposed on a reporting entity shall not exceed $500,000 in a reporting year. In setting a penalty, CARB considers all relevant circumstances, including the entity’s past and present compliance and whether it took good-faith measures to comply, and when. Keep that separate from fee enforcement: under the fee subarticle, each calendar day of a violation is a separate offense, violations may be enjoined, and an unpaid fee is a separate violation for each day it remains unpaid. The $500,000 cap and the daily fee offenses are two different mechanisms, and a compliance calendar should track both.

Finally, the recordkeeping rule that outlives the deadline: entities must keep the California tax records that prove the revenue and doing-business thresholds for five years, and produce them on request. Your applicability memo is not a one-time work product; it is a five-year file.

What changed on the way to November 10

Companies that planned against the original calendar have already been whipsawed once, and the history explains the current date. SB 219 (2024) amended SB 253 and its companion law — among other changes it moved CARB’s deadline to adopt the implementing regulation and formalized parent-level consolidation. The Initial Regulation CARB approved on February 26, 2026 set the first filing deadline at August 10, 2026. CARB withdrew that package from the Office of Administrative Law on June 24, released modified text for a 15-day comment period on July 27 deferring the deadline to November 10, 2026, resubmitted the final package on September 21, and OAL approved it effective October 12, 2026.

The lesson is not that dates move. It is that this date has finished moving: the regulation is approved and in effect, and November 10 is the deadline in the operative text.

Preparation checklist: the next three weeks

Close the applicability question in writing. Entity-by-entity revenue test on the lesser of the last two fiscal years, doing-business analysis, exemption check — signed off and filed for the five-year record.
Pick the fiscal year deliberately. Apply the February 1 rule, and where the election exists, decide whether the most recent preceding fiscal year is genuinely ready or merely newer.
Inventory what existed on December 5, 2024. That date decides whether you file numbers, file numbers built from what you had, or file the letterhead statement. Do not reconstruct this answer from memory in November.
Choose the route and format. Intake platform or email; existing report, other-program data, or CARB’s draft template. Any of them beats a late bespoke build.
Assemble the methodology context now. Boundaries, factors and their sources, GWP values, assumptions — while the people who produced the numbers still remember how.
Set the assurance posture explicitly. Filing without assurance is accepted in 2026; arriving at the second rulemaking with an unassurable inventory is the real risk. Build to the limited-assurance standard even if no provider signs this cycle.
Calendar December 10. The fee determination notice starts a 60-day payment clock, and it lands in the middle of year-end close.
Read the filing the way your insurer will. A CARB submission is a dated, signed representation about your operations. Our sister desk at Risk Coverage Hub reads the same filing as a liability document — what a missed or inconsistent filing does to penalties, D&O applications, and renewals.

One tooling note for teams starting from zero: BC ESG’s Corporate Carbon Footprint Calculator can size a Scope 1, 2, and 3 footprint quickly enough to sanity-check an inventory in progress. Use it for exactly what it is — a planning estimate built on published U.S. EPA factors, in the page’s own words not an audit, not a GHG Protocol inventory, and not a certification. It is a reasonableness check on the filing, never a substitute for it.

Frequently asked questions

Is the November 10, 2026 deadline real, or is the regulation still proposed?

It is real. The Office of Administrative Law approved CARB’s Initial Regulation on October 12, 2026 and it took effect that day. The operative regulation sets the first Scope 1 and Scope 2 reports due on or before November 10, 2026. Older CARB web pages still carry some “proposed” language; the October approval and CARB’s September 1, 2026 reporting guidance control.

Our revenue crossed $1 billion once, two years ago. Are we covered?

Probably not on that fact alone — and the reverse is also true. Applicability uses the lesser of your two previous fiscal years’ gross receipts, measured entity by entity. One spike year above $1 billion with the other year below it leaves the lesser year under the line. Two years above it puts you in, even if the current year is softer.

We have no emissions data at all. What do we file?

For the 2026 report only, if you did not possess Scope 1 or Scope 2 information and were not collecting it on or before December 5, 2024, you may submit a statement of non-reporting on company letterhead, through the intake platform or by email, before November 10, 2026. That is a first-cycle enforcement posture, not an exemption — and the statement must be true. If you were collecting data for any purpose by that date, the honest route is to report what that data supports.

Do we have to use CARB’s intake platform?

No. The 2026 Report Intake Platform is voluntary. You may file through it — it also collects contact and billing information for fee invoicing — or email your emissions report and contact information to [email protected]. CARB’s own draft reporting template is likewise voluntary for 2026; an existing annual report or data already reported to another program can serve as the filing.

Is third-party assurance required for the 2026 filing?

The statute requires limited assurance of Scope 1 and 2 disclosures beginning in 2026, with reasonable assurance from 2030. For this first cycle, however, CARB has stated it will accept 2026 submissions whether or not assurance has been obtained. Treat that as enforcement discretion for one year, not a repeal: assurance requirements from 2027 sit in CARB’s second rulemaking.

What does the filing cost, and what does a miss cost?

The annual fee is formula-based — CARB’s program costs divided across covered entities — with determination notices issued by December 10 and payment due within 60 days; the regulation does not set a fixed dollar amount. A miss costs more: administrative penalties for nonfiling, late filing, or other failure to comply can reach $500,000 in a reporting year, with good-faith compliance efforts counted in the entity’s favor, and fee violations accrue as separate daily offenses on top of that.

Is SB 261 the same deadline?

No. SB 261 is the companion climate-risk reporting law for companies over $500 million, on a biennial cycle — and its enforcement is currently enjoined by the Ninth Circuit. November 10, 2026 is an SB 253 date, for Scope 1 and Scope 2 emissions, for companies over $1 billion. The two laws share a regulation but not a deadline, a threshold, or a current enforcement posture.

October 19, 2026

Three Doors Into November 10: How the First SB 253 Filing Actually Works

California’s first corporate emissions filing is due November 10, 2026, and the regulation behind it is no longer a proposal. The Office of Administrative Law has approved CARB’s Initial Regulation — Title 17, California Code of Regulations, Article 6, sections 96070 through 96077 — and it took effect October 12. What gets filed by the deadline, though, is narrower and stranger than the headline version. For the first cycle, what you owe California depends less on what your emissions are than on what you were already doing about them on December 5, 2024.

This is the operator’s briefing: who is in the room, the three doors into the filing, the mechanics nobody reads until the week before, and the line between what is now in force and what CARB is still proposing.

First, decide whether you are in the room

SB 253 — the Climate Corporate Data Accountability Act, Health and Safety Code section 38532 — covers U.S. companies with total annual revenues over $1 billion that do business in California. “Revenue” is tested on gross receipts as California’s tax code defines them (Revenue and Taxation Code section 25120(f)(2)), using the lower of the two most recently completed fiscal years. “Doing business” borrows the tax code’s test as well: actively transacting in the state, or crossing its economic-presence thresholds on California sales, property, or payroll.

CARB’s guidance is blunt about whose job the determination is: yours. Entities are responsible for deciding whether they meet the definition of a reporting entity, including assessing their own revenue and California footprint. CARB has published a frequently-asked-questions document and sent reminder letters to organizations that may be subject to the program — if a letter arrived, treat it as a prompt to run the test, not as the test itself.

The statute behind the deadline carries penalties of up to $500,000 per reporting year for late filing, nonfiling, or other violations. The first cycle comes with a safety net, described below — but the net is CARB’s enforcement posture, not an amendment to the law.

Door one: you were already counting

CARB’s December 2024 Enforcement Notice set the line that still governs this cycle. For the 2026 report, CARB exercises enforcement discretion: you report the Scope 1 and Scope 2 emissions for your preceding fiscal year based on the information you already had, or were already collecting, when that notice was issued — whether or not the data received limited assurance.

The acceptable vehicles are deliberately unglamorous. CARB will take an existing annual report that includes your Scope 1 and Scope 2 data. It will take the data as reported to another program or voluntary initiative — the inventory already sitting in a CDP response or another filing does not need to be rebuilt in a California shape. Or you can use CARB’s Draft Scope 1 and 2 Reporting Template, posted in October 2025; its use is voluntary for this cycle.

Two details separate a filing from a number. Emissions are measured under the Greenhouse Gas Protocol, as the statute requires. And CARB encourages filers to include the context that qualifies the figures — methodologies, data sources, global warming potential values, organizational boundaries, disaggregation by category and gas, and the assumptions used. For Scope 2, no single emission-factor dataset is mandated: eGRID 2023 is acceptable, as are other credible sources, provided the report identifies the factors and where they came from.

Door two: you were not counting yet

If your company was not collecting Scope 1 and 2 data — and was not planning to — when the December 2024 notice issued, CARB does not expect an inventory for this first cycle. What it requests instead is a statement of non-reporting on company letterhead, saying exactly that, submitted before November 10 through the intake platform or by email.

Read that door carefully, because it is the one most often misdescribed. It is not an exemption from SB 253 and it is not a filing holiday. It is a one-cycle posture tied to a specific date: the discretion applies to the 2026 report only, and the facts it rests on — what you were collecting on December 5, 2024 — are either true of your company or they are not. Companies that were collecting data do not get to use the letter, and companies that use the letter should expect the posture to end with this cycle.

Assurance follows the same pattern of a hard statute and a soft first year. The law requires limited assurance on Scope 1 and 2 beginning in 2026, phasing to reasonable assurance by 2030. CARB will nonetheless accept 2026 submissions whether or not assurance has been obtained. The requirement did not move; the enforcement did.

The mechanics: platform, email, and a fee

CARB built a voluntary 2026 Report Intake Platform, released with its September 1, 2026 guidance document. Use is not mandatory. The platform collects contact information ahead of the deadline, offers fields to submit the Scope 1 and 2 report itself, and gathers billing information for fee invoicing. Anything the platform accepts can also be emailed to CARB’s climate disclosure inbox instead — the channel is your choice; the deadline is not.

The Initial Regulation also stands up the fee that funds the program: a flat annual charge per covered entity, set to cover CARB’s cost of administering it. Staff estimates during the rulemaking put the SB 253 fee in the low thousands of dollars per entity per year — roughly $3,100 — which is also why the intake platform asks for billing contacts. The fee is a rounding error next to the cost of building the inventory; the reason to register your contact information accurately is that this platform is how the program will reach you from here.

The road to this date is worth knowing, because it explains the compressed calendar. The regulation was proposed with an August 10, 2026 deadline. CARB withdrew the package in June, released modified text in July, and OAL approved the revised version in October — moving the first deadline to November 10 in the process. Companies that built their plan around August got three extra months; companies that waited for certainty got about four weeks.

What is in force, and what is still only proposed

In force today: the November 10, 2026 deadline for first-year Scope 1 and 2 reports; the definitions of revenue and doing business; the fee structure; and the enforcement-discretion posture for 2026 described above. Scope 3 reporting begins in 2027 under the statute — the emissions themselves are owed from next year, not from this filing.

Still to come: a second CARB rulemaking that will set the 2027-and-beyond machinery — accounting methodologies, deadlines, assurance requirements, and reporting formats. Anything you read about how 2027 reporting will work in detail is, at this point, a proposal moving through that process, not a rule you can file against. Build the 2026 filing to the documents that exist; design the underlying data system so it can absorb the machinery when it lands.

Do not conflate the companion law. SB 261, the climate-related financial risk act, covers a wider population (over $500 million in revenue), runs on a biennial cycle, and is currently not being enforced: the Ninth Circuit enjoined its enforcement in November 2025, and CARB has said it will not enforce the statute while the injunction stands. CARB opened a public docket in December 2025 where companies may post risk reports voluntarily. SB 261’s pause changes nothing about the November 10 SB 253 deadline.

If you also report in Europe

Dual reporters face two different instruments built on the same underlying inventory. California asks for an emissions number, measured under the GHG Protocol, from any company over the revenue line that does business in the state — regardless of where it is headquartered or listed. The EU’s CSRD, as narrowed by the Omnibus package, asks a wider question — double materiality across environmental and social topics, in ESRS format — of a differently drawn population. Our CSRD roadmap after the 2026 Omnibus walks the European side, and our regulatory convergence map tracks how the regimes line up.

The operational answer is boring and correct: one inventory, documented once, with the methodology trail kept at a standard that satisfies the strictest reader, then rendered into each regime’s format. Groups can report to California at the parent level, which keeps a multi-subsidiary structure from fragmenting into dozens of inconsistent filings. What does not transfer is the assurance clock and the legal posture — California’s good-faith first year is California’s alone.

For a facilities-level view of what the November 10 numbers set in motion inside buildings and portfolios, see our companion piece, November 10 Is Locked. The filing itself, though, is a three-week problem now: run the applicability test, establish which side of December 5, 2024 your company was on, and put the report — or the letter — through one of the doors before November 10.

Risk Coverage Hub, our sister desk, reads the same filing as an insurance document — what a signed emissions statement does inside a D&O application, a greenwashing defense, and a renewal.

October 19, 2026

Beauty Companies’ Executive Pay and Sustainability Targets: How Beauty Ties Pay to Packaging, Sourcing and ESG in 2026

Executive pay tied to sustainability targets in beauty companies means a disclosed share of executive variable pay — annual bonus, performance shares, or both — depends on achieving the sustainability commitments the brand makes to consumers: recycled and bio-based packaging, responsibly sourced ingredients, lower-carbon operations, and the social programs attached to the products. Beauty is the consumer industry where the sustainability claim is printed on the pack and sold at the shelf, which makes it the industry where investors test hardest whether executive pay actually stands behind the claim.

Definition — sustainability-linked executive pay (beauty and consumer brands): an incentive design in which part of executive variable remuneration is assessed against the company’s published sustainability targets. In beauty, the recurring target families are packaging circularity (recycled, refillable, reusable or bio-based content), responsible sourcing (certified palm oil, traceable bio-based ingredients), carbon and site performance, and social measures such as gender balance and community programs.

This guide examines how beauty and consumer-brand companies structure that link in 2026: the disclosed mechanics at L’Oréal and Unilever, the packaging and sourcing targets that sit behind the pay metrics at the big houses including The Estée Lauder Companies, how disclosure differs between Europe and the United States, and what investors check before they believe any of it.

Why do beauty companies link executive pay to sustainability targets?

Beauty companies link executive pay to sustainability targets because their sustainability performance is commercially visible in a way most industries’ is not. A shampoo bottle’s recycled content, a lipstick’s refill system, a cream’s ingredient story — these are product attributes consumers can inspect, regulators increasingly require to be substantiated, and competitors advertise against. When the claim is part of the product, the board’s question follows naturally: if sustainability sells the product, why would it not move the pay of the people who run the company?

Three pressures convert that logic into plan design. First, greenwashing exposure: consumer-facing claims attract regulator and litigant attention, and a pay plan that rewards only sales while marketing claims sustainability is a documented inconsistency waiting to be quoted. Second, disclosure law: European beauty houses report under the EU’s sustainability framework and publish remuneration policies that shareholders vote on, making the pay–sustainability link a matter of public record. Third, investor methodology: proxy advisors now test whether non-financial pay metrics are objective, quantified and financially underpinned — a standard that pushes beauty boards from narrative commitments to formulaic targets.

Which sustainability targets show up in beauty executive pay?

The sustainability targets in beauty executive pay cluster into five families: packaging circularity, carbon and site performance, responsible sourcing, composite sustainability indices, and social measures. The disclosed examples are drawn from the companies’ own registration documents, annual reports and sustainability reporting.

Target family	Where it sits	Disclosed structure
Packaging circularity	Performance shares; program targets behind pay	L’Oréal: the share of plastic packaging from recycled or bio-based sources is a named non-financial criterion in executive performance shares; its 2030 program targets a 50% absolute reduction in virgin plastic use against 2019 and 50% of packaging materials from recycled or bio-based sources
Carbon and sites	Annual variable pay and performance shares	L’Oréal: the share of sites with carbon-neutral status is a named performance-share criterion; the program commits to 100% renewable energy on operated sites and a 57% cut in Scope 1 and 2 emissions by 2030 against 2019
Responsible sourcing	Performance shares; supply-chain goals	L’Oréal: the share of formula ingredients that are bio-sourced, traceable and from sustainable sources is a named pay criterion; The Estée Lauder Companies reported 95% of palm-based ingredients certified sustainable through RSPO physical supply chains in fiscal 2024
Composite sustainability index	Long-term incentive (performance share plan)	Unilever: the Sustainability Progress Index carries 15% of the Performance Share Plan, measured on four core measures with target ranges set for three-year periods
Social measures	Performance shares and annual objectives	L’Oréal: the number of people benefiting from its brands’ social commitment programs and gender balance in strategic positions are named criteria; its program also targets living-wage pledges from 100% of strategic suppliers

The pattern to notice is that beauty’s pay metrics are physical and countable — percentages of packaging, percentages of ingredients, counts of sites and beneficiaries. That is partly the industry’s good fortune (its footprint is tangible) and partly investor discipline: physical metrics are the ones that survive a proxy advisor’s objectivity test.

How does L’Oréal tie executive pay to L’Oréal for the Future?

L’Oréal operates the most completely disclosed sustainability pay structure in the beauty industry, documented in its Universal Registration Document. The link runs through both elements of variable pay.

In the annual variable remuneration, financial criteria carry 60% of the weighting. Quantifiable non-financial criteria carry 25%, of which progress under L’Oréal for the Future — the group’s sustainable development program for 2030 — accounts for 10 percentage points, with the balance of the quantifiable block covering sustainability training and digital development. The remaining 15% is qualitative assessment. The weighting of each criterion and its objectives are set at the start of the year, and the assessment is made without offsetting between criteria — a miss on the sustainability block cannot be silently compensated by a financial beat.

In performance shares, the long-term element, non-financial criteria sit alongside financial ones over a three-year assessment period with a four-year vesting horizon. The named environmental and social criteria are:

the percentage of sites with carbon-neutral status;
the percentage of formula ingredients that are bio-sourced, traceable and come from sustainable sources;
the percentage of plastic packaging that comes from recycled or bio-based sources;
the number of people benefiting from the group’s brands’ social commitment programs;
gender balance within strategic positions, including the Executive Committee.

This is the complete grammar of the beauty model in one plan: packaging, sourcing, carbon and social outcomes, each expressed as a measurable percentage or count, assessed over a multi-year period, in a document shareholders can read.

The targets behind the pay metrics: L’Oréal for the Future to 2030

Pay metrics are only as credible as the program targets they sample, and L’Oréal for the Future is the reference program for the sector. Its published 2030 commitments — the targets from which the pay criteria above are drawn — include:

Climate: 100% renewable energy use on operated sites and stores; absolute Scope 1 and 2 greenhouse-gas emissions reduced 57% against 2019; specified Scope 3 categories reduced 28% against 2019.
Circularity: virgin plastic used for product packaging reduced 50% in absolute terms against 2019; 50% of all materials used in product packaging sourced from recycled or bio-based sources; packaging intensity reduced 20% against 2019.
Nature and sourcing: at least 90% of bio-based materials used in formulas and packaging sustainably sourced; more than 75% of ingredients sourced from nature or recycled materials; 100% recycled or reused water for industrial purposes in factories.
Communities: 100,000 people from disadvantaged communities helped into employment; 100% of strategic suppliers signing a living-wage pledge with a time-bound action plan; 10 million people supported through brands’ social engagement programs.

Two features matter for pay design. The targets are absolute and baseline-dated (against 2019), which makes them auditable and prevents intensity-only improvements from masquerading as progress while volumes grow. And the program’s four pillars — climate transition, nature, circularity, communities — map one-to-one onto the metric families in the pay plan, so a shareholder can trace any pay criterion back to a public commitment.

How does Unilever pay on sustainability? The Sustainability Progress Index

Unilever — parent of Dove, Sunsilk, Vaseline and a portfolio of beauty and personal-care brands alongside its foods and home-care businesses — uses the sector’s best-known composite mechanism: the Sustainability Progress Index (SPI) inside its Performance Share Plan (PSP).

In the PSP scorecard disclosed in Unilever’s 2025 Annual Report, relative total shareholder return carries 30%, average underlying return on invested capital carries 30%, and the Sustainability Progress Index carries 15%. The SPI is not a single metric but a governed index: under Unilever’s renewed approach it concentrates on four core measures, with target ranges set for a three-year period and disclosed prospectively, subject to external review by an external provider or internal review where external review is not possible, and assessed formulaically against the published ranges. Awards vest after three years with a further two-year retention period, and clawback, malus and recovery provisions apply across the plan.

The SPI design answers the standard objection to composite ESG measures — that an index lets management hide a miss inside an average. Four measures instead of the previous eight, ranges published in advance, external review, and a formulaic assessment are the specific countermeasures, each one visible in Unilever’s remuneration policy documents. For consumer brands generally, the lesson is that a composite index can carry pay weight credibly, but only when its construction is as disclosed as a single metric would be.

Packaging targets: beauty’s most measurable promise

Packaging is where beauty sustainability becomes arithmetic. A bottle either contains post-consumer recycled resin or it does not; a compact is either refillable or it is not. That measurability is why packaging percentages anchor so many beauty pay metrics — and why packaging is also where claims discipline is most exposed.

The reference points across the big houses:

L’Oréal writes the share of plastic packaging from recycled or bio-based sources directly into executive performance-share criteria, against program targets of halving virgin plastic use by 2030 (against 2019) and sourcing 50% of packaging materials from recycled or bio-based sources.
The Estée Lauder Companies set a goal that by 2025, 75–100% of its packaging would be recyclable, refillable, reusable, recycled or recoverable, with post-consumer recycled content targeted to rise by up to 50%. Its fiscal 2024 Social Impact and Sustainability Report recorded 71% of packaging meeting that standard — progress disclosed against the target, short of it, in the company’s own reporting.
Unilever’s packaging ambitions feed the SPI rather than a standalone pay line, illustrating the index route: packaging progress moves executive outcomes as part of the composite, not as a separate percentage.

The disclosure contrast inside that list is itself instructive. A target with a published current value (71% against a 75–100% goal) is more useful to an investor than a target alone, because it converts the pay question from “did they promise?” to “did the trajectory earn?” — the question compensation committees must answer when they set the following cycle’s ranges.

Responsible sourcing metrics: palm oil, mica and bio-based ingredients

If packaging is beauty’s most measurable promise, sourcing is its most exposed one. The industry’s ingredient footprint runs through palm oil and its derivatives, mica, shea, vanilla and hundreds of botanical supply chains — exactly the terrain where deforestation, labor and traceability risks concentrate, and where a brand’s sustainability claim can be falsified by a single supply-chain investigation.

The disclosed sourcing metrics follow the same physical grammar as packaging:

Certified palm oil. The Estée Lauder Companies reported achieving its 2025 palm oil goal ahead of schedule in fiscal 2024, with 95% of palm-based ingredients certified sustainable by the Roundtable on Sustainable Palm Oil (RSPO) through physical supply chains — the stricter certification route, rather than book-and-claim certificates.
Traceable bio-based ingredients. L’Oréal’s performance-share criteria include the share of formula ingredients that are bio-sourced, traceable and from sustainable sources — three conditions, not one, which is what makes the metric resistant to relabeling.
Ingredient transparency. The Estée Lauder Companies published a corporate ingredient glossary covering more than 100 key ingredients, meeting its transparency goal ahead of schedule; transparency artifacts like this are increasingly treated by investors as governance evidence behind sourcing claims.

For pay design, sourcing metrics carry a distinctive risk: the data comes from the supply chain, not the general ledger. Credible structures therefore specify the certification or traceability standard inside the metric definition (RSPO physical supply chain; “traceable and from sustainable sources”) rather than leaving the evidence standard to the assessment year.

How do US and European beauty companies differ on ESG pay disclosure?

The transatlantic difference in beauty ESG pay is primarily a difference in disclosure architecture, not in sustainability ambition. The European houses publish formulaic structures: L’Oréal’s Universal Registration Document states the exact weights (60% financial, 25% quantifiable non-financial, 15% qualitative in the annual variable; named non-financial criteria in performance shares), and Unilever publishes its PSP weights and SPI construction in its remuneration policy and annual report. A shareholder can compute the maximum pay consequence of a sustainability miss from the documents alone.

US beauty disclosure runs through the proxy statement’s compensation discussion, which describes performance frameworks in terms of financial measures and strategic or individual objectives. The Estée Lauder Companies illustrate the pattern: the company publishes detailed sustainability goals and reports progress against them in a dedicated Social Impact and Sustainability Report — 71% of packaging meeting its recyclability standard, 95% of palm-based ingredients RSPO-certified, a 23% reduction in water withdrawal against its fiscal 2019 baseline — while its executive-pay disclosure does not attach a disclosed percentage weighting to ESG outcomes of the kind found in the European documents.

Investors read the two patterns differently. The European structure makes the pay link falsifiable: if the sustainability block pays out in full while the published program metrics stall, the inconsistency is arithmetically visible. The US pattern leaves the link to committee judgement, which places the burden on retrospective explanation. Neither pattern guarantees rigor, but they distribute the burden of proof differently — and the direction of regulatory travel on both continents is toward the falsifiable end.

What gets disclosed — and what investors check

Across both patterns, investors evaluating beauty sustainability pay apply a consistent checklist, drawn from proxy-advisor methodology and say-on-pay engagement practice:

Is there a stated weight? A disclosed percentage (L’Oréal’s 10 points for its sustainability program inside annual variable pay; Unilever’s 15% SPI in the PSP) versus an unquantified statement that ESG is “taken into account.”
Are the metrics objective and quantified? ISS’s framework asks whether incentive programs emphasize objective metrics linked to quantifiable goals rather than discretionary ones, and whether the rationale for metric selection and changes is clearly explained. Limited or undisclosed goals were the most-cited qualitative concern in ISS’s negative say-on-pay recommendations in the first half of the 2026 proxy season.
Are non-financial metrics financially underpinned? Glass Lewis’s 2026 benchmark guidelines state that where remuneration outcomes rely predominantly on qualitative or non-financial metrics without financial underpins or gateways, it may recommend voting against the remuneration policy or report.
Are targets set prospectively and outcomes reconciled? Unilever’s prospective three-year SPI ranges and L’Oréal’s no-offsetting rule are the disclosed mechanisms; both exist so that outcomes can be checked against intentions.
Does progress data exist outside the pay document? A pay metric sampled from a public program with its own progress reporting (71% against a packaging goal; 95% RSPO certification) can be cross-examined; a metric that exists only inside the remuneration report cannot.

Greenwashing risk: when the pack claims more than the pay plan does

The beauty industry’s specific greenwashing risk is a gap between the consumer claim and the pay plan. Marketing tells the shopper the brand is transforming its packaging; if no executive’s pay moves when packaging transformation stalls, the claim is structurally unserious, and that gap is legible to regulators, journalists and plaintiff firms in a way that a missing ESG metric in, say, industrial software is not.

Credible beauty structures close the gap with four habits visible in the disclosed examples in this guide. They attach pay to the same metrics the marketing cites (recycled content, certified sourcing), not to a safer internal proxy. They express targets absolutely and against fixed baselines, so volume growth cannot launder intensity-only gains. They put the evidence standard inside the metric definition (RSPO physical supply chains; traceable and sustainably sourced). And they publish progress against the target in the sustainability report, including when progress is short — The Estée Lauder Companies’ 71% against a 75–100% packaging goal is more credibility-preserving than a rounded claim of success, because it demonstrates the reporting system works when the news is incomplete.

For the cross-industry design framework — weighting, baselines, metric selection and greenwashing controls — see BC ESG’s guide to ESG-linked compensation and executive accountability, and for the metric definitions behind target-setting, the complete professional guide to ESG metrics. The pay-equity and workforce-data side of consumer-brand ESG reporting is covered in BC ESG’s guide to DEI metrics, pay equity and ESG reporting.

Frequently asked questions

Which beauty companies tie executive pay to sustainability targets?

The clearest disclosed structures are European. L’Oréal’s Universal Registration Document states that quantifiable non-financial criteria carry 25% of annual variable remuneration — including 10 percentage points for progress under its L’Oréal for the Future sustainability program — and that its performance shares carry named non-financial criteria covering carbon-neutral sites, bio-sourced and traceable ingredients, recycled or bio-based plastic packaging, social program reach and gender balance. Unilever’s Performance Share Plan weights its Sustainability Progress Index at 15%. The Estée Lauder Companies publish detailed sustainability goals and progress but do not disclose a formulaic ESG weighting in executive pay of the kind set out in the European documents.

What sustainability targets are used in beauty executive pay?

The named criteria in L’Oréal’s performance shares are the industry’s reference list: the percentage of sites with carbon-neutral status; the percentage of formula ingredients that are bio-sourced, traceable and from sustainable sources; the percentage of plastic packaging from recycled or bio-based sources; the number of people benefiting from the group’s brands’ social commitment programs; and gender balance within strategic positions. Unilever’s Sustainability Progress Index concentrates on four core sustainability measures assessed against target ranges set for three-year periods.

How much of beauty executive pay depends on sustainability?

Where weights are published, sustainability carries a defined minority of variable pay. At L’Oréal, 10 of the 25 quantifiable non-financial points in annual variable remuneration are assigned to progress under its sustainability program, within a structure weighted 60% to financial criteria; its performance shares add further non-financial criteria over a three-year assessment. At Unilever, the Sustainability Progress Index carries 15% of the Performance Share Plan, alongside relative total shareholder return at 30% and underlying return on invested capital at 30%.

What packaging targets sit behind beauty sustainability pay?

L’Oréal’s program targets a 50% absolute reduction in virgin plastic for product packaging by 2030 against 2019, and 50% of packaging materials from recycled or bio-based sources, while the share of plastic packaging from recycled or bio-based sources is itself a named executive performance-share criterion. The Estée Lauder Companies set a goal of 75–100% of packaging being recyclable, refillable, reusable, recycled or recoverable by 2025, and reported 71% of packaging meeting that standard in fiscal 2024.

How do investors verify beauty sustainability pay claims?

Investors cross-examine the pay document against the public program. ISS evaluates whether incentive metrics are objective and linked to quantifiable goals, and whether the rationale for metric selection and changes is disclosed. Glass Lewis’s 2026 guidelines add that pay outcomes relying predominantly on qualitative or non-financial metrics without financial underpins or gateways may draw a vote against the remuneration policy or report. The strongest structures pre-answer both tests: stated weights, physical metrics with fixed baselines, prospective target ranges, and progress published in the sustainability report even when it falls short of the goal.

October 19, 2026

Pharmaceutical Companies’ ESG Executive Compensation: How Pharma Ties Pay to Access, Safety and Sustainability in 2026

ESG executive compensation in pharmaceutical companies is the practice of tying a defined share of executive incentive pay — annual bonus, performance shares, or both — to environmental, social and governance outcomes that are material to a drugmaker: access to medicines, patient safety and product quality, pipeline delivery, and carbon reduction. In pharma, the “S” in ESG is not generic social language. It is whether patients can obtain the medicine, whether the product is safe, and whether the data behind it can be trusted — and pharmaceutical companies have begun writing exactly those outcomes into the pay plans of the executives who control them.

Definition — ESG-linked executive compensation (pharmaceuticals): an incentive design in which a disclosed portion of executive variable pay vests or pays out against non-financial targets drawn from the company’s material ESG issues. In pharmaceutical companies the recurring metric families are access to medicines, carbon and environmental footprint, patient safety and product quality, and governance measures such as ethics and compliance — assessed over one year in the annual bonus or over three or more years in performance-share plans.

This guide examines how pharmaceutical companies structure ESG executive compensation in 2026: which metrics they choose, where those metrics sit in the pay mix, what the disclosed structures at Sanofi, Novartis, GSK and AstraZeneca actually say, what gets disclosed to shareholders, and what ISS and Glass Lewis scrutinize when they evaluate these plans.

Why do pharmaceutical companies tie executive pay to ESG outcomes?

Pharmaceutical companies tie executive pay to ESG outcomes because the industry’s licence to operate is itself an ESG question. A drugmaker’s social impact is not a side program; it is the product. Pricing and access decisions determine whether medicines reach patients in low- and middle-income countries. Manufacturing quality failures become patient-safety events. Clinical-trial conduct becomes a governance question. When those are the material risks, compensation committees increasingly treat them as pay-relevant performance, not as narrative.

Three pressures drive the design. First, large institutional investors ask for it directly and engage on the specifics — metric selection, weighting and target rigor — rather than accepting a generic commitment. Second, external benchmarks make performance comparable: the Access to Medicine Index ranks major pharmaceutical companies on access practices, giving boards a published yardstick they can reference in pay design. Third, proxy advisors evaluate ESG pay metrics on quality, not presence: a metric that is vague, discretionary or undisclosed now counts against a say-on-pay recommendation instead of for it.

The result is a distinctive pharma pattern. Financial and pipeline measures still dominate the pay mix. ESG measures sit alongside them at disclosed weights, concentrated in the areas where pharma’s footprint is unique: access, safety, quality and carbon.

Which ESG metrics do pharmaceutical companies put in executive pay?

The ESG metrics pharmaceutical companies put in executive pay cluster into five families: access to medicines, carbon reduction, patient safety and product quality, pipeline and innovation delivery, and trust or governance measures. The disclosed examples below are drawn from company compensation reports, registration documents and annual reports — the structures boards have actually published, not survey averages.

Metric family	Where it typically sits	Disclosed structure
Access to medicines	Long-term incentive (performance shares)	Sanofi: “Affordable Access” — supplying essential medicines for non-communicable diseases through the Sanofi Global Health Unit — is one of two CSR objectives carrying 20% of its performance-share conditions
Carbon reduction	Long-term incentive and annual objectives	Sanofi: “Planet Care” — Scope 1 and 2 emissions reduction against a 2019 baseline — is the second CSR objective; AstraZeneca flags its greenhouse-gas reduction KPI as used for Executive Director remuneration
Responsible business and trust	Annual bonus	GSK: annual bonus combines financial, operational and Responsible Business measures, with Responsible Business performance assessed with input from its Corporate Responsibility Committee
ESG targets in annual objectives	Annual bonus scorecard	Novartis: members of the Executive Committee and other senior leaders carry ESG targets in their annual objectives
Patient safety, quality and compliance	Modifier, underpin or gateway	Commonly applied as a gate or downward modifier rather than a weighted scorecard line, so a serious safety or compliance failure can reduce pay earned on other measures

Two design facts stand out from the disclosed structures. The metrics are overwhelmingly company-specific — access through a named global-health unit, carbon against a named baseline year — because generic sector metrics would not survive investor scrutiny. And the heaviest ESG weightings appear in long-term incentives, where three-year measurement matches the horizon over which access programs and emissions pathways actually move.

How does Sanofi structure ESG criteria in executive pay?

Sanofi operates the most fully specified ESG pay structure disclosed by a large pharmaceutical company. In its performance-share plans, extra-financial (CSR) criteria account for 20% of the performance conditions, assessed over a three-year period. The criteria rest on two objectives:

Affordable Access: providing essential medicines for the treatment of non-communicable diseases through the Sanofi Global Health Unit.
Planet Care: reduction of Scope 1 and 2 carbon emissions against a 2019 baseline.

The mechanics are formulaic rather than discretionary. Attainment of each annual CSR objective earns performance points, with an additional point available for a stretch objective; at the end of the period the points convert to a CSR allocation rate that runs from 0% (fewer than three points) through 100% at six points to a maximum of 120% at eight points. The structure is disclosed in Sanofi’s regulatory filings on the compensation of its corporate officers, including the exact conversion table — shareholders can recompute the outcome themselves.

Below the long-term plan, Sanofi also applies sustainability inside short-term pay. Its published executive-compensation materials describe an individual sustainability performance criterion representing 10% of annual variable compensation, and state that all Executive Committee members carry collective sustainability objectives covering people and climate topics in their annual variable packages. The design is therefore layered: a collective floor for the whole executive team, an individual criterion for named officers, and the 20% CSR weighting in the long-term plan on top.

How do Novartis and GSK link executive pay to ESG targets?

Novartis and GSK illustrate the two other common architectures: ESG targets embedded in annual objectives, and a responsible-business block inside the annual bonus.

Novartis integrates ESG at the objective-setting level. The company’s ESG reporting states that members of the Executive Committee and other senior leaders have ESG targets in their annual objectives, inside a compensation system the company describes as rewarding sustainable growth and value creation, with engagement with shareholders and proxy advisors on how the link is built. Access is one of Novartis’s stated ESG commitments — expanding access to its medicines globally — and the objective-level design means ESG performance is assessed for the executives accountable for it each year rather than only at the end of a three-year plan.

GSK runs its non-financial element through the annual bonus. GSK’s remuneration framework combines financial, operational and strategic measures with Responsible Business measures set at the start of the year, with performance against those measures assessed by the Remuneration Committee and, where appropriate, the Corporate Responsibility Committee. At least 50% of the bonus is assessed against financial measures, and part of any bonus earned is deferred into shares for three years. Third-party assessment puts the scale of the link in context: Sustainalytics’ ESG risk research on GSK notes that around 10% of executive pay is tied to ESG metrics, and that GSK operates a board-level Corporate Responsibility Committee overseeing ESG performance. GSK is also ranked first on both the Access to Medicine Index and the Access to Vaccines Index in that research — the access performance its pay structure is designed to reinforce.

The contrast between the three companies is instructive. Sanofi discloses a hard weighting and a formula. GSK discloses a governed assessment process with a financial floor. Novartis discloses objective-level integration. All three are defensible; they differ in how much of the judgement shareholders can verify from outside, which is precisely what proxy advisors grade.

How does AstraZeneca connect executive remuneration to its climate targets?

AstraZeneca connects remuneration to its Ambition Zero Carbon strategy. Its annual-report KPI framework explicitly flags the greenhouse-gas reduction measure as used for the remuneration of Executive Directors — an unusually direct disclosure that tells shareholders exactly which sustainability KPI carries pay consequences.

The targets behind the KPI are absolute and dated. AstraZeneca aims to reduce Scope 1 and 2 emissions by 98% by 2026 against a 2015 baseline, reported an 88.1% reduction achieved by 2025, targets a 50% reduction in Scope 3 emissions by 2030, and follows a science-based net-zero pathway to 2045 that was verified by the Science Based Targets initiative. The company has backed the strategy with more than US$1 billion of investment in decarbonising its operations and value chain, including fleet electrification and action on high-impact sources such as fluorinated gases used in inhaler production.

For pay design, the AstraZeneca structure matters because the metric is a physical quantity with a fixed baseline, reported in the same KPI table as revenue and pipeline events. That is the form of ESG metric investors consistently rate most credible: measurable without interpretation, auditable against a public baseline, and impossible to re-scope quietly mid-cycle.

Access to medicines: the metric that defines pharma’s “S”

Access to medicines is the metric that defines the social component of pharmaceutical ESG pay, because it measures the industry’s core externality: whether the products reach the patients who need them, in the countries least able to pay. Unlike a generic diversity or community metric, access can be specified operationally — products supplied, countries covered, patients reached through dedicated access units — and it is externally benchmarked.

The Access to Medicine Index, published by the Access to Medicine Foundation, ranks research-based pharmaceutical companies on access practices in low- and middle-income countries. Its existence changes pay design in two ways. It gives compensation committees a defensible external reference when they set access targets, and it gives investors a comparison set when they judge whether a company’s access claims — and the pay outcomes built on them — are credible.

Sanofi’s structure shows the direct application: its Affordable Access objective is defined as providing essential medicines for non-communicable diseases through the Sanofi Global Health Unit, the company’s dedicated access vehicle, and it carries half of the 20% CSR weighting in the long-term plan. Access is not decorative in that design; it is worth a measurable slice of the chief executive’s equity outcome. GSK’s first-place ranking on the Index, noted in third-party ESG research, illustrates the reputational side of the same coin — the companies whose access performance leads the benchmark are the ones whose boards can most safely attach pay to it.

Patient safety, quality and compliance: the gate metrics

Patient safety, product quality and compliance usually enter pharmaceutical pay plans as gates and modifiers rather than weighted scorecard metrics. The logic is asymmetric: excellent safety performance is the expected baseline of the business, while a single major failure — a manufacturing-quality crisis, a data-integrity finding, a serious compliance breach — can destroy value on a scale no bonus scorecard anticipates. Boards therefore design these measures to subtract, not to add.

The standard mechanisms are:

Underpins or gateways: no payout, or a capped payout, on some or all of the incentive if a defined safety, quality or compliance threshold is breached.
Malus and clawback: unvested awards can be reduced or forfeited, and paid awards recovered, where misconduct or material failure emerges — provisions ISS expects to extend beyond legal minimums, covering time-vesting awards as well as performance awards.
Committee discretion with disclosure: a documented power to adjust formulaic outcomes downward for risk events, with the adjustment and its rationale disclosed in the following compensation report.

Investors scrutinize this layer hardest after an incident. A pay outcome that lands at or above target in a year containing a major quality or compliance failure — with no visible modifier applied — is one of the most reliable triggers of a say-on-pay protest, because it tells shareholders the ESG language in the plan was never load-bearing.

Pipeline and R&D incentives: paying for innovation without paying for hype

Pipeline delivery is the ESG-adjacent metric family unique to pharmaceutical pay. Research productivity is a governance question as much as a scientific one: capital allocation into R&D shapes the company’s long-term social contribution and its largest long-horizon risks. Pharmaceutical bonus and long-term plans therefore typically carry pipeline progression, regulatory milestones and launch execution inside their operational or strategic measure blocks — GSK’s annual bonus, for example, includes pipeline measures alongside its financial and Responsible Business elements.

The design tension is target quality. A milestone metric rewards events (filings, approvals, phase transitions) that are partly outside management’s control and can incentivize optimistic timelines; a purely financial plan avoids that problem by ignoring the pipeline entirely, which misprices the business. Credible structures handle it by mixing leading indicators management controls — trial starts, enrolment, data readouts delivered on schedule — with lagging outcomes, and by keeping pipeline measures inside a broader scorecard rather than letting a single approval dominate a pay year. What investors resist is retrospective redefinition: milestones quietly re-scoped after a delay, or strategic measures assessed entirely on narrative. Both patterns feature in proxy-advisor criticism of pharma pay.

What gets disclosed in pharmaceutical proxy statements and compensation reports?

Disclosure is where pharmaceutical ESG pay is won or lost, because the same structure reads as rigorous or as decoration depending on what shareholders can see. The strongest disclosed packages — Sanofi’s filings are the clearest example in this guide — share four features:

The weighting is stated. Shareholders can see that CSR criteria carry 20% of performance-share conditions, not that ESG is “considered.”
The targets are identifiable. Named objectives (essential-medicines access through a named unit; Scope 1 and 2 reduction against a 2019 baseline) replace category labels.
The conversion mechanics are published. Points-to-allocation tables and payout ranges let an investor recompute the outcome.
Outcomes are reported against the same measures. Retrospective disclosure closes the loop: what was targeted, what was achieved, what was paid.

European issuers disclose under say-on-pay regimes that require a remuneration policy vote and an annual report vote; US issuers disclose through the proxy statement’s Compensation Discussion and Analysis. In both systems the direction of travel is identical — from narrative commitment toward quantified, auditable linkage — and in both systems the gaps investors cite are the same: undisclosed forward targets, unexplained metric changes, and outcomes that cannot be reconciled to the measures originally set.

What do ISS and Glass Lewis scrutinize in pharmaceutical ESG pay?

ISS and Glass Lewis do not require ESG metrics in pay, and neither prescribes which metrics a pharmaceutical company should use. What they grade is rigor and disclosure quality, and their published positions define the tests a pharma pay plan must pass:

Objective, quantifiable goals. ISS’s policy framework asks whether an incentive program emphasizes objective metrics linked to quantifiable goals, as opposed to metrics that are highly discretionary, and whether the rationale for selecting — or changing — metrics is clearly disclosed. ISS has also signalled that mid-cycle changes to in-flight awards are generally viewed negatively without a compelling rationale.
Undisclosed goals are the leading red flag. In ISS’s review of the first half of the 2026 proxy season, limited, opaque or undisclosed performance goals were the most frequently cited qualitative factor behind its negative say-on-pay recommendations — cited for 27 of the 36 S&P 500 companies that received one.
Financial underpins for non-financial metrics. Glass Lewis’s 2026 benchmark guidelines state that where remuneration outcomes rely predominantly on qualitative or non-financial metrics without financial underpins or gateways, it may recommend voting against the remuneration policy or report. Glass Lewis assesses pay holistically, with disclosure quality an explicit input.
Clawback strength. ISS expects clawback policies that exceed minimum legal requirements; a plan whose recovery provisions stop at the regulatory floor reads as unfinished.

Applied to pharma, the tests are concrete. An access metric defined by a named program with published targets passes the objectivity test; a “progress on our ESG journey” measure fails it. A carbon metric against a fixed, disclosed baseline passes; a baseline reset mid-cycle without rationale fails. The companies in this guide that disclose formulas and conversion tables are, in effect, publishing their answers to these tests in advance.

Design principles for credible ESG executive compensation in pharma

The disclosed structures that survive investor scrutiny share a common design grammar:

Weight ESG where it is material, and say the weight. Access, safety, quality and carbon carry disclosed percentages; everything else is narrative and is treated as such.
Put slow metrics in long-term plans. Access programs and emissions pathways move over years; three-year performance shares fit them better than annual bonuses.
Define metrics operationally. A named unit, a named baseline year, a named external benchmark — definitions an outsider can test.
Gate the catastrophic risks. Safety, quality and compliance operate as underpins, malus and clawback, so failures subtract before scorecards add.
Keep financial measures dominant. GSK’s floor of at least 50% financial weighting in the bonus is the sector’s centre of gravity; ESG measures steer, they do not replace, financial and pipeline performance.
Publish the mechanics, then the outcome against them. Formula first, retrospective reconciliation second — the order is what makes the outcome believable.
Never re-scope mid-cycle without a stated rationale. Proxy advisors treat unexplained changes as evidence the original targets were not real.

For the cross-industry framework behind these principles — weighting, baselines and greenwashing controls — see BC ESG’s guide to ESG-linked compensation and executive accountability, and for the metric definitions that underpin target-setting, the complete professional guide to ESG metrics.

Frequently asked questions

How much of pharmaceutical executive pay is tied to ESG?

The disclosed structures cluster in a clear band. Sanofi weights extra-financial criteria at 20% of the performance conditions in its performance-share plans. Sustainalytics’ research estimates that around 10% of GSK executive pay is tied to ESG metrics, delivered through Responsible Business measures in the annual bonus. Novartis takes a third route, placing ESG targets in the annual objectives of its Executive Committee members and other senior leaders rather than publishing a single plan-level weight.

What ESG metrics do pharmaceutical companies use in executive compensation?

The recurring metric families are access to medicines (for example, Sanofi’s objective of supplying essential non-communicable-disease medicines through its Global Health Unit), carbon reduction against a fixed baseline (Sanofi’s Scope 1 and 2 target against 2019; AstraZeneca’s greenhouse-gas KPI, which its annual report flags as used for Executive Director remuneration), patient safety and product quality — usually applied as gates or modifiers — pipeline and regulatory milestones, and governance measures covering ethics and compliance.

Why is access to medicines the defining ESG pay metric in pharma?

Access to medicines is the defining social metric in pharmaceutical pay because it measures the industry’s core social impact — whether medicines reach patients in low- and middle-income countries — in operational units that can be targeted and audited. It is also externally benchmarked by the Access to Medicine Index, which ranks major pharmaceutical companies on access practices and gives boards and investors a published reference point for judging both targets and outcomes.

How do proxy advisors evaluate ESG metrics in pharmaceutical pay plans?

ISS evaluates whether incentive programs emphasize objective metrics linked to quantifiable goals rather than discretionary measures, and whether the rationale for metric selection and any changes is disclosed; in its review of the first half of the 2026 proxy season, opaque or undisclosed goals were its most-cited concern in negative say-on-pay recommendations. Glass Lewis’s 2026 guidelines add a structural test: where pay outcomes rely predominantly on qualitative or non-financial metrics without financial underpins or gateways, it may recommend voting against the remuneration policy or report.

Do ESG metrics replace financial and pipeline targets in pharma pay?

No. In every disclosed structure reviewed for this guide, financial performance remains the largest component of pharmaceutical executive pay — GSK, for example, assesses at least 50% of its annual bonus against financial measures — and pipeline and operational measures carry substantial weight alongside it. ESG metrics steer a defined minority of the outcome, typically 10–20% where a weight is published, with safety, quality and compliance operating mainly as gates that can reduce pay rather than as scorecard lines that add to it.

October 19, 2026

Pozzotive Is Selling the Attribute, Not the Material
On October 14, Urban Mining Industries and S3 Markets announced the issuance of Environmental Attribute Certificates for Pozzotive, the ground-glass pozzolan Urban Mining produces in Beacon Falls, Connecticut — described in the release as the world’s first EACs issued for a supplementary cementitious material. The mechanism is book-and-claim: the environmental attribute of the material is separated from the material itself, so a buyer whose projects sit far outside Pozzotive’s shipping range can acquire its emissions-reduction attributes without a single tonne changing hands.

Book-and-claim is not a gimmick. It is how renewable electricity attributes have traded for two decades, and it is how sustainable aviation fuel certificates work today. But in every market where it has become credible, the certificate rests on published paperwork: a defined unit, a methodology anyone can read, a named verifier, and a retirement record a stranger can inspect. The Pozzotive launch, on its public materials, currently offers none of those four. That does not make the claim false. It makes it unsubstantiated — and for a compliance reader deciding whether the claim can enter a Scope 3 inventory, a bid, or a marketing line, the difference is the whole job.

The material underneath is real. Its paperwork is from 2020.

Pozzotive itself is not vaporware. It is post-consumer glass milled to a fine powder, used to replace a portion of portland cement in concrete. Sales in 2025 were reported at more than 20,000 tons; its largest application to date is the JPMorgan Chase headquarters tower in Manhattan, built with roughly 52,000 cubic yards of Pozzotive concrete. The product has a genuine track record as a material.

The documented basis for its carbon claim is thinner and older. The quantitative evidence in public is a pre-production screening LCA from around 2020, which puts Pozzotive’s footprint at 56 kg CO2e per tonne against a U.S. industry-average portland cement figure of 1,040 kg CO2e per tonne. That study was written before the plant was in production, from engineering estimates — and it says so, describing a three-phase plan that was supposed to end in a product-specific, third-party-verified Type III EPD built on twelve months of actual production data. As of this month, no such product EPD for Pozzotive can be found in the public EPD sources. What exists are EPDs for concrete mixes that contain Pozzotive, which is a different document about a different product.

Readers will meet the headline figure in three versions: 93% lower (the October release), 95% less (the screening LCA, per tonne against industry-average cement), and 94% less (a project case study, against a different cement average of 922). The spread is not necessarily dishonest — the percentages move because the denominator moves. But a certificate programme has to fix one denominator, one functional unit, in writing. So far, none is fixed.

One tonne of Pozzotive is not one tonne of avoided cement emissions

The certificate’s value is determined by displacement, and displacement is arithmetic with two inputs a buyer should be able to reproduce. A tonne of Pozzotive avoids emissions only to the extent that, in an actual mix, it replaces clinker-bearing cement at an achieved replacement rate without the total binder content rising to compensate. At a 1:1 replacement against the industry-average factor, the screening numbers imply roughly 984 kg of avoided CO2e per tonne. Use a manufacturer-specific cement factor — the screening LCA itself notes real cements run closer to 800 kg — and a realized replacement rate below 1:1, and the figure falls materially.

Two details in the launch language deserve a careful read. The release says issuance accounts for “the potential SCM replacement rates.” Certificates issued against potential displacement are a different instrument from certificates issued against realized displacement. And Pozzotive is also marketed as a functional filler for paints, coatings, adhesives, and polymers — end uses that displace no cement at all. If certificates are issued on production tonnes rather than on tonnes verified in cementitious use, the counterfactual under part of the issued volume can fail entirely. The issuers say an adjustment methodology exists. It is not published.

What credible book-and-claim looks like

The precedent ledger is instructive because the credible systems all converged on the same five elements: a fixed physical unit tied to a verified production event; serialization in a registry the seller does not unilaterally control; retirement as the exclusive, third-party-visible claim event; an independent verifier working to a named standard; and written rules for what the physical buyer of the underlying product may claim.

Renewable Energy Certificates have the full stack — metered generation, regional registries, retirement, Green-e oversight, and GHG Protocol quality criteria. SAF certificates have it: the fuel is certified first under ISCC or RSB, and a not-for-profit registry run by RMI, EDF, and partners handles issuance and retirement. The RIN market under the Renewable Fuel Standard shows the cost of building the stack late — fraudulent credits for fuel never produced cost obligated parties more than $200 million before the EPA imposed third-party quality assurance, with buyers bearing the loss on invalid credits even when they bought in good faith. And the closest cement precedent, Microsoft’s 2025 agreement to buy Sublime Systems’ cement with its EACs separable by book-and-claim, specified independent third-party verification as a headline term — while still describing the registry infrastructure as a future system being built.

Against that template: the Pozzotive certificates are issued on S3 Markets’ own platform, held in S3’s custodial accounts, and retired on S3’s ledger. S3 describes its infrastructure as “aligned with” the ISO 22095 book-and-claim model and as “mapping to” the AIM Platform’s v1.0 standard — its own verbs, self-declared, with no conformance assessment by either body referenced. The release does not state what one certificate represents. It names no verifier and no assurance standard. It publishes no registry a third party can search. None of this proves the underlying tonnes are wrong. All of it means an outside reader currently has to take the seller’s word for the seller’s product.

The fault line specific to this launch: the physical product already carries the claim

Generic double counting is not the sharpest risk here. The specific one is double claiming between the certificate and the concrete. Pozzotive’s low footprint already flows, today, into the environmental product declarations of the concrete mixes that physically contain it — claimed, properly, by the producers and project teams who bought the material. If the same tonne’s attribute is also sold as a certificate to a distant buyer, the benefit exists in two ledgers at once: once in a project-level mix EPD, once in a certificate retirement.

Every mature book-and-claim system answers this with a written allocation rule: when the attribute is sold separately, the physical product is de-characterized — its buyers must report it at a default factor, because the low-carbon attribute now belongs to someone else. The Pozzotive launch materials state no such rule. Until they do, a certificate buyer cannot know whether the attribute they retired is exclusively theirs, and a physical buyer cannot know whether the EPD benefit they are reporting has also been sold. This single document — the attribute-allocation policy — is the fastest credibility win available to the issuers, and the first thing a competitor, an auditor, or a journalist will ask for.

The accounting rules have not caught up — and the pitch has

Whatever the paperwork eventually shows, a buyer today should be clear about what the certificate can legally do inside an inventory. Under the GHG Protocol’s current Scope 3 standard, the answer is: nothing. That standard is an attributional, physical-flow inventory; market-based instruments exist only for Scope 2, under quality criteria. There is no current mechanism by which a book-and-claim certificate for a material you did not physically buy reduces your reported Scope 3 Category 1 footprint. Netting one in today is ahead of the standard, not compliant with it.

The rules are moving — which is precisely why claim language matters now. The GHG Protocol’s Actions and Market Instruments workstream has proposed multi-statement reporting: the physical inventory stays foundational, a market-based statement would extend contractual instruments to Scopes 1 and 3 (its materials expressly name commodity certificates for cement), and in the interim companies are instructed to report the figures separately, without netting. A consultation on the draft standard is scheduled for Q2 2027. SBTi’s revised standard moves the same direction: EACs for commodities usable at activity-pool or sector level, reported separately from the inventory, as an interim progress instrument. As this desk noted when California’s climate deadline held while the federal one slid, reporting regimes right now are a set of clocks running at different speeds — and a certificate bought against tomorrow’s rules carries restatement risk under today’s.

Set against that, S3’s buyer-facing language promises “valid, defensible Scope 3 reduction claims.” Those words are doing more work than the current rulebooks allow. The AIM Platform’s v1.0 framework — the market-built quality bar — caps any intervention claim at the quantity of the component actually in the reporter’s own inventory and requires the intervention to be associated with the reporter’s value chain; S3 says its infrastructure “maps to” AIM, which is a self-assessment, not an evaluation against those tests.

What to demand before the claim holds

For a compliance reader meeting this certificate in an inventory, a supplier file, or a bid, the substantiation requests are concrete. Each one is answered by a document, not a conversation:
1. The certificate definition sheet — what one EAC represents, in what unit, against what functional basis.
2. The issuance methodology — the cement baseline factor, the replacement-rate rule (realized, not “potential”), and whether issuance requires verified cementitious end use.
3. Serialization with a public retirement record — a lookup a third party can run, naming the beneficiary and date of retirement.
4. The attribute-allocation policy — the written rule for what physical buyers of uncertificated Pozzotive may claim in their EPDs.
5. The product-specific Type III EPD — third-party verified, built on production data, under the new consolidated cementitious PCR; or an explicit acknowledgment that the factor still rests on the 2020 screening study.
6. The verifier’s name and standard — an ISO 14065-accredited body with a published verification statement, or clarity that verification is the platform’s own process.
7. The invalid-certificate clause — who makes the buyer whole if a batch is later found over-issued; the RIN market’s default answer was “nobody,” until the rules changed.
8. The accounting treatment, in advance — your assurance provider’s concurrence that the certificates will be reported separately from the physical inventory, before the purchase, not at audit. If the claim will be marketed in California, an AB 1305 applicability review belongs in the same file; in the EU, note that certificates cannot support a consumer-facing climate-neutral product claim at all under the Empowering Consumers Directive, whatever their quality.
The fork

None of this argues against the instrument. Cement is a spot market with thin margins, novel SCMs struggle to finance capacity, and a long-term attribute revenue stream is a rational answer — it is the additionality story that makes the financing narrative credible, especially for forward purchases funding new capacity. The GHG Protocol is building a home for exactly this instrument class. The direction of travel is not in doubt.

What is in doubt is only whether this launch does the paperwork. It becomes credible if a product EPD publishes, the methodology is public, a named accredited verifier attests issuance, and retirements become inspectable by strangers. It fails if certificates turn out to be issued on production tonnes regardless of end use, if the physical product keeps its EPD benefit in parallel with the certificate, or if “Scope 3 reduction” marketing keeps outrunning the separate-statement treatment every relevant rulebook currently requires. Both paths are still open. Which one the issuers choose over the next two quarters is the story — and it will be decided by documents, so ask for the documents.
October 18, 2026
California’s Climate Deadline Is Firm. The Federal One Just Slid to 2027.

California’s first corporate emissions reports are due on November 10, 2026, and that date is now final. On October 12, the state’s Office of Administrative Law approved the Air Resources Board’s regulation implementing SB 253, closing the last procedural step between the law and the companies it covers. Four days earlier and three time zones away, the U.S. EPA published a rule moving the federal greenhouse gas reporting deadline for the same emissions era out of 2026 entirely, to March 10, 2027. A company with obligations in both systems now plans to two calendars moving in opposite directions.

What California just locked in

SB 253, the Climate Corporate Data Accountability Act, requires U.S. companies doing business in California with more than $1 billion in annual revenue to disclose their greenhouse gas emissions to the California Air Resources Board (CARB). The first reports cover Scope 1 and Scope 2 emissions — direct emissions and purchased energy — and they are due November 10, 2026. CARB’s preliminary list identified more than 4,000 U.S. companies likely in scope, and the regulator has sent reminder letters to companies it believes are covered.

The November date is itself a moved deadline, which is worth understanding before treating it as permanent. Initial reporting was first set for August 10, 2026. CARB withdrew its regulation from review in June to make limited changes and resubmitted it, pushing the first deadline to November. The difference this time is procedural posture: the regulation has now been approved and is in effect, the reporting guidance and intake platform are published, and the fee schedule starts December 10, when CARB begins issuing annual fee determination notices, payable within 60 days. A deadline with a fee notice attached behaves differently from a deadline in a draft rule.

A firm date with a soft first-year bar

The deadline is hard. The data standard for the first cycle is deliberately forgiving, and the regulation says so in three distinct ways. A reporting company can satisfy November 10 with a Scope 1 and 2 report for its applicable preceding fiscal year. It can instead submit emissions data drawn from information it already had, or was collecting, on or before December 5, 2024 — CARB’s enforcement-notice baseline. Or, if it held no such data and was not collecting it by that date, it can file a statement on company letterhead saying exactly that. First-cycle reports are accepted without limited assurance, and CARB has said it will exercise enforcement discretion for this inaugural cycle.

That structure is a design choice, not a loophole. California is buying a complete census of who reports before it buys precision in what they report. Assurance tightens on a published schedule: limited assurance over Scope 1 and 2 begins with the 2027 cycle, Scope 3 value-chain reporting also begins in 2027, and reasonable assurance arrives in 2030. A company that treats the soft first year as a reason to wait is misreading the sequence — the 2026 filing is the baseline the assured filings will be compared against.

One sibling law needs separating from this deadline. SB 261, which requires companies over $500 million in revenue to publish climate-related financial risk reports, is under a Ninth Circuit injunction pausing its implementation while an appeal runs. The same court declined to halt SB 253. The November 10 emissions deadline is not paused, and a risk-report delay is not an emissions-report delay.

The federal side: one reporting year, three dates

The federal Greenhouse Gas Reporting Program collects emissions data from roughly 8,200 facilities, fuel and industrial-gas suppliers, and carbon dioxide injection sites under 40 CFR Part 98. Its reporting-year 2025 reports were originally due March 31, 2026. A February 2026 rule moved that to October 30, 2026. On October 14, 2026, EPA published an interim final rule, effective immediately, moving it again — to March 10, 2027. One reporting year has now carried three deadlines, each announced as the program’s future was being reconsidered. We covered the federal move and what to do with the extra time in full: EPA Moved the 2025 GHG Reporting Deadline to March 10, 2027.

The reason for the slide is stated in the rule itself. EPA is deciding what to do with its September 2025 reconsideration proposal, which would rework reporting requirements for nearly every source category in the program and suspend the remaining natural-gas-segment obligations until 2034. The agency says it needs the time, and that its reporting system would not have been ready for the October date. The extension changes only the deadline: reporting-year 2025 reports remain owed, and comments on the interim rule are open until November 30, 2026.

Two systems, two populations, one planning problem

These two deadlines are often described as substitutes. They are not. The federal program is facility-level: a plant reports its own emissions because it crosses a source threshold. California’s SB 253 is company-level: an enterprise reports its Scope 1 and 2 footprint because its revenue and its California business cross a statutory line. A manufacturer can owe EPA a facility report in March 2027, owe CARB a corporate report this November, both, or neither — and the data systems behind the two filings overlap without being identical.

The practical reading for compliance teams is sequencing. California’s calendar is the one now in force, with a named date, an open intake platform, and fees that start in December; it sets the working timeline for corporate disclosure regardless of what Washington decides. The federal timeline is genuinely uncertain, but uncertain is not cancelled — records that support a reporting-year 2025 facility filing still need to exist in March 2027 unless the reconsideration removes the obligation outright. And the assurance runway California published — limited assurance in 2027, reasonable assurance in 2030 — means the emissions inventory a company files this November, under good-faith flexibility, becomes the foundation its auditors test later. The state held its date and eased its standard. The federal government eased its date and left its question open. Companies reporting into both should build to the calendar that is actually running.

October 18, 2026

EPA Moved the 2025 GHG Reporting Deadline to March 10, 2027 — What Building Owners Should Do With the Extra Time

The short answer: if your facility reports under the EPA’s Greenhouse Gas Reporting Program, your 2025 report is now due March 10, 2027 — not October 30, 2026. The EPA moved the deadline for the second time in a year, in an interim final rule effective October 14, 2026, and it changed nothing else. The reason for the move is the story: the agency is still deciding whether the 2025 report should exist at all.

What exactly changed

One date. The interim final rule (Federal Register, October 14, 2026, document 2026-20982) extends the reporting deadline for reporting year 2025 under the Greenhouse Gas Reporting Rule (40 CFR Part 98) from October 30, 2026 to March 10, 2027. In the EPA’s own words, the action “only changes the reporting deadline for annual greenhouse gas reports for reporting year 2025 and makes no other changes to the rule.”

The rule took effect the day it published. The EPA is accepting comments on it until November 30, 2026 (Docket ID EPA-HQ-OAR-2025-0186, via regulations.gov).

How the deadline got here: three moves in thirteen months

Date	What happened	RY2025 deadline after the move
Standing rule	GHGRP annual reports are due March 31 each year, filed through the e-GGRT system	March 31, 2026
September 16, 2025	EPA proposes reconsidering the whole program (90 FR 44591) — including a proposal that no industries would need to submit reports for calendar year 2025 at all. The proposal draws over 50,000 comments	June 10, 2026 (proposed)
February 27, 2026	EPA final rule (91 FR 9712) extends the deadline to buy time on the reconsideration	October 30, 2026
October 14, 2026	Interim final rule extends it again, expressly so EPA can finish weighing those comments and take final action on the reconsideration first	March 10, 2027

Read the sequence for what it is: the agency has now twice declined to collect a report it is actively considering abolishing. The March 2027 date is real, and it is also a placeholder in a fight about whether the program continues in anything like its current form.

Who this actually applies to

Not every building owner — and it matters to know which side of the line you are on. The Greenhouse Gas Reporting Program covers owners and operators of facilities that report under 40 CFR Part 98: large direct emitters, fuel and industrial-gas suppliers, and carbon sequestration sites. Most commercial buildings never file.

The category that catches building owners is general stationary fuel combustion — facilities running large boilers, process heaters, turbines, and engines. The EPA’s own list of affected entities for this rule includes health services and educational services: a big hospital campus or university with a central plant can be a Part 98 reporter. If your organization has filed through e-GGRT before, this deadline is yours. If you have never filed, a deadline extension for a program you are not in changes nothing for you directly — though the signals below still apply.

The decision the delay actually creates

A moved deadline is not a cancelled one. Three things are true at once, and a sensible owner plans around all three:

The obligation still stands. Until the EPA finalizes the reconsideration, reporting year 2025 remains a required report with a due date of March 10, 2027. Treating the extension as a repeal is a bet, not a reading of the rule.
The repeal is genuinely possible. The September 2025 proposal would have eliminated the 2025 reporting obligation entirely. If the final action lands anywhere near the proposal, the March 2027 deadline may never be used. The EPA took this extension specifically to finish that decision before the deadline arrives.
Your 2025 data has other masters. The fuel records, meter data, and calculations behind a federal report are the same records that state programs, lenders, insurers, tenants, and corporate ESG disclosures ask for — on their own schedules, none of which paused. The cheapest time to assemble 2025 data was while 2025 was happening; the second-cheapest time is now, while the records are still warm.

The practical posture: stop the scramble, keep the file. You no longer need a finished report by the end of October. You do need your 2025 fuel and emissions records gathered, consistent, and retrievable — because every plausible ending (program retained, program narrowed, program ended but state and market demands continuing) rewards the owner who kept the data and penalizes the one who used the delay as a reason to discard it.

Frequently asked questions

What is the new deadline for 2025 greenhouse gas reports?

March 10, 2027. The EPA’s interim final rule of October 14, 2026 moved it from October 30, 2026. It is the second extension for reporting year 2025; the original due date was March 31, 2026.

Did the EPA cancel 2025 GHG reporting?

No. The EPA has proposed eliminating the 2025 reporting obligation as part of its reconsideration of the Greenhouse Gas Reporting Program, and it received over 50,000 comments on that proposal. Until a final action is published, the report remains required — just due later.

Does this affect building owners?

Directly, only if your facility reports under 40 CFR Part 98 — most often large properties with substantial on-site fuel combustion, such as hospital campuses, universities, and industrial sites. Most individual commercial buildings are not GHGRP reporters. Indirectly, the data discipline still matters: state programs and private ESG requests use the same underlying records and have not paused.

Can I comment on the rule?

Yes. Comments on the interim final rule are due by November 30, 2026, under Docket ID EPA-HQ-OAR-2025-0186, through regulations.gov. Most individual owners will feel the outcome more than they shape it; industry associations are the realistic channel for owner input.

What should a reporting facility do now?

Re-calendar the deadline to March 10, 2027, keep the 2025 data collection intact, and watch for the final reconsideration action — it, not this extension, decides whether the report is ever filed.

BC ESG tracks the filing duties and deadlines that land on building owners — federal, state, and market-driven — and explains what each one actually requires. This summary is general information, not compliance advice for a specific facility.

October 17, 2026

What Does ETS2 Mean for Building Owners?

On October 16, 2026, EU leaders closed a summit argument that building owners across Europe had been watching for months. A group of member states — Italy, Poland, Hungary, Slovakia, and Czechia among them — wanted the bloc’s new carbon market for buildings and road transport, known as ETS2, postponed again, this time to 2030. Germany, France, Spain, and the Nordics held the line. The outcome: ETS2 stays, the 2028 start stands, and the European Commission will produce an updated assessment of the system’s impacts, design, and safeguards.

For building owners, the debate is now settled enough to plan against. Here is what ETS2 actually is, where its cost lands, and what to do in the fourteen months before it prices your heating fuel.

What is ETS2, exactly?

ETS2 is a second, separate emissions trading system alongside the EU’s original ETS for power and heavy industry. It covers fuel combustion in three places the first system never reached: buildings, road transport, and small industry. Its cap is set to cut those sectors’ emissions 42% by 2030 against 2005 levels.

Two design choices define it. First, it is regulated upstream: the obligated parties are fuel suppliers, not building owners or drivers. Suppliers monitor and report the emissions embedded in the fuels they sell — that reporting has been running since 2025 — and from 2028 they must surrender one allowance for every tonne, starting with surrenders due by May 31, 2028 for the first compliance year. Second, every allowance is auctioned, and early auctions begin in January 2027, a full year before obligations bite, so a market price will exist well before the first bill does.

Who actually pays?

Not the building owner — on paper. Owners file nothing and surrender nothing. But a fuel supplier’s allowance cost is a cost of selling fuel, and it will be priced into gas and heating oil the way every upstream cost is. From 2028, fossil heating carries a visible carbon component, set by an auction market rather than by a tax schedule.

That distinction matters commercially. A carbon tax arrives as a known number in a budget line. A carbon market arrives as volatility: the same building’s heating cost will move with allowance prices, futures curves, and weather-driven demand. Owners with gas or oil heat should expect energy procurement — not compliance — to be where ETS2 shows up first: in supply contracts, in pass-through clauses, and in the lease negotiations over who bears fuel costs that neither party fully controls.

How high can the price go?

ETS2 was designed with a softener its older sibling never had. If the allowance price exceeds €45 per tonne (in 2020 prices), the market stability reserve automatically releases additional allowances to pull it back — 40 million at a time under the strengthened deal the Council endorsed on October 9, 2026, double the original design, available twice a year. The reserve’s full 600 million allowances now remain available beyond 2030 instead of being cancelled, and a further rapid-release trigger exists if allowances in circulation fall below 260 million.

Read that correctly: the €45 mechanism is a shock absorber, not a ceiling. It fires on spikes, in fixed quantities, and the cap still shrinks every year toward the 42% reduction. Early ETS2 futures have traded firm. The prudent planning assumption is a heating-fuel carbon cost that starts managed and trends upward — which is precisely the investment signal the system’s defenders, including a 50-organization industry coalition that publicly urged a no-delay 2028 start, say owners and suppliers need.

What cushions exist?

The political price of pricing household fuel is paid through the Social Climate Fund, which channels ETS2 revenues to vulnerable households, micro-enterprises, and transport users — insulation, clean heating systems, cleaner mobility — under national Social Climate Plans each member state must adopt. Member states must spend their auction revenues on climate and social measures and report on them, and an EIB frontloading facility exists to pull investment forward before the first surrender deadline.

For owners, the practical translation: support for the transition is real but national. What a landlord in Lyon, a housing association in Brno, and a small hotel group in Naples can each claim will differ, because each government writes its own plan. The EU sets the price; the member state sets the cushion.

What should building owners do before 2028?

Inventory the exposure. Which buildings burn what, under which contracts, with boilers at what age? ETS2 risk concentrates exactly where fossil heating, long remaining equipment life, and leases that push fuel costs onto the owner overlap.

Model the scenarios, not the forecast. Run the portfolio at €45, then at prices above the trigger where the reserve releases no longer fully bite. The output isn’t a prediction — it’s the size of the electrification question, per building, in euros per square metre.

Treat every boiler end-of-life as a decision point. Replacing a gas boiler in 2027 with another gas boiler is now a fifteen-year bet against a shrinking cap. Heat pumps and district-heating connections should be priced against the carbon-inclusive cost of gas, not today’s price — the same whole-life carbon accounting discipline BC ESG applies to Scope 1, 2, and 3 measurement.

Fix the lease language now. Green-lease clauses that allocate fuel-carbon costs, data sharing, and retrofit cooperation are cheap to negotiate at renewal and expensive to argue about after the first carbon-inclusive invoice.

Watch two documents. The Commission’s updated ETS2 impact assessment (the summit’s one concession to the delay camp) and your member state’s Social Climate Plan together will tell you the real local shape of 2028 — with a scheduled ETS2 review in 2029 as the next decision point after that.

The summit’s message, stripped of diplomacy: the carbon price on buildings is no longer a proposal that might slip. It is a market that starts pricing in January 2027 and starts billing in 2028. Owners who treat the next fourteen months as a planning window will meet it as a line item. Owners who don’t will meet it as a surprise.

October 16, 2026

Blog

The deal, in one pass

The timing mismatch is the market’s core problem

How the structure re-slices the risk

What the offtake does — and what it does not do

When this shape works

What the buffer pool is doing in the first place

What the framework actually changes

When substitution holds up — and when it weakens protection

Why this matters beyond reforestation

What “missed” actually means for your building

The four pathways, one by one

What is still open this late in the cycle

The delay and relief routes

What it costs if you fall short anyway

The owner’s checklist for the rest of 2026

What it proves — and what it doesn’t

The boundary matters

The questions to ask your own merchants

The filing in one table

Who must file — and who is out

Which fiscal year goes in the first filing

The no-data door, stated precisely

How to file in 2026

Assurance: the requirement versus the first-year enforcement

Fees, penalties, and the five-year file

What changed on the way to November 10

Preparation checklist: the next three weeks

Frequently asked questions

Is the November 10, 2026 deadline real, or is the regulation still proposed?

Our revenue crossed $1 billion once, two years ago. Are we covered?

We have no emissions data at all. What do we file?

Do we have to use CARB’s intake platform?

Is third-party assurance required for the 2026 filing?

What does the filing cost, and what does a miss cost?

Is SB 261 the same deadline?

First, decide whether you are in the room

Door one: you were already counting

Door two: you were not counting yet

The mechanics: platform, email, and a fee

What is in force, and what is still only proposed

If you also report in Europe

Why do beauty companies link executive pay to sustainability targets?

Which sustainability targets show up in beauty executive pay?

How does L’Oréal tie executive pay to L’Oréal for the Future?

The targets behind the pay metrics: L’Oréal for the Future to 2030

How does Unilever pay on sustainability? The Sustainability Progress Index

Packaging targets: beauty’s most measurable promise

Responsible sourcing metrics: palm oil, mica and bio-based ingredients

How do US and European beauty companies differ on ESG pay disclosure?

What gets disclosed — and what investors check

Greenwashing risk: when the pack claims more than the pay plan does

Frequently asked questions

Which beauty companies tie executive pay to sustainability targets?

What sustainability targets are used in beauty executive pay?

How much of beauty executive pay depends on sustainability?

What packaging targets sit behind beauty sustainability pay?

How do investors verify beauty sustainability pay claims?

Why do pharmaceutical companies tie executive pay to ESG outcomes?

Which ESG metrics do pharmaceutical companies put in executive pay?

How does Sanofi structure ESG criteria in executive pay?

How do Novartis and GSK link executive pay to ESG targets?

How does AstraZeneca connect executive remuneration to its climate targets?

Access to medicines: the metric that defines pharma’s “S”

Patient safety, quality and compliance: the gate metrics

Pipeline and R&D incentives: paying for innovation without paying for hype

What gets disclosed in pharmaceutical proxy statements and compensation reports?

What do ISS and Glass Lewis scrutinize in pharmaceutical ESG pay?

Design principles for credible ESG executive compensation in pharma

Frequently asked questions

How much of pharmaceutical executive pay is tied to ESG?

What ESG metrics do pharmaceutical companies use in executive compensation?

Why is access to medicines the defining ESG pay metric in pharma?

How do proxy advisors evaluate ESG metrics in pharmaceutical pay plans?

Do ESG metrics replace financial and pipeline targets in pharma pay?

The material underneath is real. Its paperwork is from 2020.

One tonne of Pozzotive is not one tonne of avoided cement emissions

What credible book-and-claim looks like

The fault line specific to this launch: the physical product already carries the claim

The accounting rules have not caught up — and the pitch has